Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,16113,144,2.81 [1.06-7.44],0.0371522463549216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,15641,140,0.97 [0.71-1.33],0.8554913257993289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,18440,167,1.05 [0.82-1.34],0.7236169477330215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,15563,139,0.99 [0.62-1.58],0.9758416996873284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,18322,166,0.89 [0.70-1.14],0.3700178015521032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,18440,167,0.95 [0.77-1.16],0.5957270341607557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,16110,145,1.02 [0.91-1.13],0.7855898703150513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,15563,139,0.79 [0.61-1.02],0.0731245496949218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",18107,161,1.00 [0.84-1.20],0.9564758853006404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",15807,138,0.83 [0.62-1.10],0.1951621417943725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",16089,144,0.84 [0.70-1.01],0.0682982406319138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,18330,164,1.23 [0.74-2.05],0.4280855761622707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,16110,145,0.76 [0.43-1.33],0.3344812590090181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,18197,158,0.88 [0.67-1.16],0.3643771765127905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,15738,143,0.76 [0.47-1.23],0.2643690422869037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,16036,144,0.97 [0.84-1.11],0.6210943048706711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,18528,166,0.80 [0.60-1.07],0.1286606179166261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,15604,137,0.86 [0.59-1.26],0.4430829584007463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,18604,165,0.98 [0.65-1.49],0.9260502072477754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,18678,165,0.89 [0.74-1.08],0.2537081341562899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,16032,144,0.66 [0.42-1.02],0.0610723771762687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,15604,137,0.89 [0.76-1.05],0.1662269808435796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,15563,139,1.02 [0.64-1.61],0.9491264206521182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",18197,158,1.50 [1.17-1.93],0.0012741648502444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,15563,139,1.00 [0.77-1.30],0.9790139425641936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,18216,160,1.09 [0.72-1.64],0.6901687713532851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,18344,165,2.09 [1.26-3.46],0.0043178697563238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,18528,166,1.00 [0.80-1.25],0.9682813468723256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,15563,139,0.91 [0.67-1.23],0.5230855622249542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,15688,141,1.01 [0.79-1.30],0.9068385338043288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,18751,169,1.26 [0.89-1.79],0.1977060544674608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,18443,162,2.21 [1.66-2.94],5.4140931662917124e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,15604,137,1.97 [1.34-2.90],0.0005794627888039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,18197,158,1.50 [0.95-2.35],0.078930177450766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,18379,166,1.30 [0.89-1.91],0.1776423772937537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,18751,169,1.27 [0.85-1.90],0.2516590501815688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,18665,169,3.38 [2.46-4.64],5.509907066044508e-14
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,16036,144,2.47 [1.57-3.87],8.356586216738678e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,15604,137,1.03 [0.61-1.74],0.9100035865138144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,18759,168,0.60 [0.34-1.04],0.0679478774433659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,18440,167,1.03 [0.73-1.45],0.8582007879824012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,18197,158,1.06 [0.71-1.58],0.7781297476359035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,15604,137,0.80 [0.50-1.29],0.3607695979566778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,18574,169,0.67 [0.50-0.89],0.0065002205533521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,16098,144,0.83 [0.51-1.35],0.4584741654087091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,15641,140,1.47 [0.76-2.85],0.2482906574686349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,16089,144,0.84 [0.56-1.25],0.3920606451678629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,18107,161,0.77 [0.46-1.28],0.3116027411756029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,15738,143,0.81 [0.65-1.02],0.0739353477766914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,18344,165,0.88 [0.58-1.34],0.5517518701765874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,15738,143,0.65 [0.43-0.98],0.0389141745620148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,16036,144,1.98 [1.53-2.57],1.9128262505678e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,18589,167,2.66 [1.72-4.13],1.201131425317707e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,18668,167,2.34 [1.73-3.15],2.4270537644325685e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,16089,144,1.31 [0.72-2.39],0.3840224308518611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,18440,167,1.04 [0.89-1.22],0.6038162841639889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,18528,166,1.17 [0.70-1.96],0.5562554911410396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,15598,136,0.96 [0.75-1.23],0.7417824558383346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,15738,143,0.83 [0.66-1.03],0.0936376333587406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,18197,158,1.01 [0.85-1.20],0.9198832440177048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,16113,144,1.25 [1.00-1.58],0.0549404491532868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,18701,165,1.47 [0.85-2.54],0.1652616369816076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,15563,139,0.88 [0.68-1.15],0.352232537169427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,15738,143,0.94 [0.77-1.14],0.5295189894760306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFM,Afamin,16113,144,0.41 [0.19-0.89],0.0242330169891734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,18309,163,1.26 [1.02-1.56],0.0299320275110844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,15598,136,0.88 [0.75-1.03],0.1134779631171366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,18468,166,1.03 [0.74-1.45],0.8553450301563925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,18001,163,1.17 [1.02-1.35],0.0263512797179235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,18081,161,0.99 [0.78-1.26],0.9260403109753806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,18589,167,1.49 [1.02-2.19],0.0392314930379367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,18751,169,1.05 [0.81-1.37],0.7033097041968946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,16110,145,0.86 [0.40-1.87],0.708741028428787
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,18528,166,1.08 [0.90-1.30],0.3839823245827801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,18528,166,0.91 [0.74-1.12],0.3647967823049198
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,15641,140,1.64 [1.03-2.60],0.0371496940574297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,15641,140,1.17 [0.71-1.95],0.5337990967757272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,16032,144,0.90 [0.69-1.17],0.4355749456475533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,16110,145,1.29 [0.72-2.31],0.387690185514568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,18492,168,1.00 [0.85-1.18],0.9977755313765692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",15673,134,0.97 [0.80-1.18],0.7716821131572851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,18107,161,1.20 [0.92-1.57],0.1683903933700342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,15641,140,0.77 [0.54-1.11],0.1601096139451361
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",18417,167,0.99 [0.87-1.13],0.8828265372639771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,18528,166,0.91 [0.73-1.13],0.4036924092779166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",16058,142,0.94 [0.80-1.09],0.3869376297952173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,15738,143,1.35 [0.66-2.74],0.4066685131006793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,18107,161,1.04 [0.86-1.26],0.6737871160525606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,15673,134,1.10 [0.86-1.41],0.4558019002009801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,18197,158,1.05 [0.80-1.38],0.7302393214245364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,15604,137,1.04 [0.82-1.32],0.7445959718003257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,18133,164,0.96 [0.78-1.18],0.6949668676763787
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,16064,141,0.92 [0.82-1.05],0.2195448994948588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,18020,160,0.95 [0.74-1.21],0.6567778802033484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,18759,168,2.20 [1.11-4.37],0.0240819556240682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,18530,168,1.00 [0.78-1.29],0.9860045207195612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",16032,144,0.75 [0.50-1.11],0.149770615712015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",18493,168,1.05 [0.86-1.27],0.6498328202312637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",16064,141,0.90 [0.63-1.29],0.5675617864824193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,15807,138,1.10 [0.77-1.58],0.5906772418305455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,15604,137,0.95 [0.83-1.09],0.4708372306388727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",18440,167,1.03 [0.90-1.17],0.6479146339708818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,18216,160,0.85 [0.49-1.49],0.5710377725936917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,18675,165,1.27 [0.63-2.53],0.5035648746977999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,16098,144,1.34 [0.72-2.48],0.361277732244552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,18133,164,1.09 [0.89-1.35],0.4042550480397974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,15673,134,0.76 [0.51-1.12],0.161283481500078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,18440,167,1.15 [0.64-2.07],0.6297364364210221
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,18216,160,1.11 [0.82-1.49],0.4986000394261756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,15738,143,0.73 [0.47-1.13],0.1610817906882706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,15966,144,1.07 [0.78-1.47],0.6799744639558354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,16058,142,1.03 [0.82-1.30],0.7746714442591482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,15086,137,1.37 [1.05-1.78],0.0193710147132049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,17854,160,0.97 [0.72-1.29],0.8118928752386965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,17294,153,0.96 [0.71-1.28],0.762204362991415
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,18501,163,1.02 [0.67-1.56],0.9193926719321368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,18451,165,0.95 [0.81-1.12],0.5668639041630816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,18701,165,1.32 [0.92-1.89],0.1259460988800825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,18245,161,1.18 [0.73-1.92],0.4939589911971886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,18521,167,1.21 [0.85-1.71],0.2858931534734811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,18561,164,1.24 [0.83-1.86],0.2919620441448168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,18567,166,1.47 [1.08-2.00],0.0144463466334226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,18701,165,0.95 [0.65-1.39],0.7921193278515263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,15563,139,0.91 [0.70-1.17],0.4632341069163035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,15604,137,0.83 [0.67-1.03],0.0840222590949003
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,15529,136,0.99 [0.74-1.34],0.9610611753983438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,18107,161,0.90 [0.70-1.17],0.4256681118010627
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,15641,140,0.90 [0.58-1.41],0.6462909558936883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,18591,165,0.91 [0.54-1.53],0.7186567267804091
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,15658,142,1.24 [0.90-1.70],0.189750454008552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,18133,164,1.04 [0.88-1.23],0.6314125888497836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,18487,168,0.87 [0.71-1.06],0.1637728908910793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,15416,138,1.16 [0.94-1.45],0.1711370084657313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,18665,169,0.94 [0.77-1.14],0.5156997940710544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,18449,166,0.94 [0.78-1.14],0.5365269070950789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,18070,164,1.01 [0.63-1.60],0.982481280351477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],18216,160,0.93 [0.71-1.22],0.6134689767970827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,18617,166,1.16 [0.73-1.85],0.5400993485076022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,16032,144,0.94 [0.77-1.15],0.5620343373358917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,15673,134,1.06 [0.75-1.49],0.7389448269968326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,16036,144,0.91 [0.73-1.12],0.3582197684954049
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,16058,142,1.01 [0.72-1.40],0.9724841084016316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,18440,167,1.45 [1.14-1.85],0.0025152437453722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,15967,142,1.42 [0.85-2.37],0.175662656270043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,18650,165,1.13 [0.90-1.42],0.2876330643555292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,18528,166,0.99 [0.75-1.30],0.9308889605454892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,16113,144,0.82 [0.44-1.55],0.5498531543150771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,16110,145,1.15 [0.84-1.59],0.3785825683623178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,16113,144,1.17 [0.74-1.85],0.5006678428383414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,16110,145,1.06 [0.53-2.12],0.8599624224761944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,15641,140,0.68 [0.48-0.98],0.0386684634301043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,16086,142,0.67 [0.43-1.05],0.0816190193259913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,15391,131,0.91 [0.58-1.43],0.6896568411313844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,16113,144,1.14 [0.94-1.39],0.1863501444414423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,16110,145,1.44 [0.75-2.76],0.2710092455696183
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,18530,168,0.75 [0.51-1.09],0.1343850215205926
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,16110,145,1.26 [0.96-1.65],0.0973897692862662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,18594,165,0.71 [0.44-1.14],0.1528275538047995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,18505,167,0.92 [0.75-1.13],0.4166970896838453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,15738,143,0.88 [0.76-1.01],0.0775616905764366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,18349,166,1.06 [0.79-1.42],0.7135587406162063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,15807,138,1.07 [0.85-1.34],0.5892191261139812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,18440,167,1.38 [0.99-1.93],0.0597537543858263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,16036,144,0.91 [0.79-1.06],0.2257349083237534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,16064,141,0.81 [0.64-1.03],0.0882287023546499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,18425,164,1.06 [0.81-1.38],0.6718038582628798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",16032,144,0.86 [0.57-1.30],0.4769318254091842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,18107,161,0.96 [0.71-1.29],0.7730593553322166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,18107,161,1.17 [0.95-1.45],0.1477006436999312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,15807,138,1.12 [0.78-1.60],0.5448513233724094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,15738,143,0.91 [0.74-1.10],0.3245080182856688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,15529,136,0.69 [0.53-0.91],0.0074070257170059
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,16058,142,0.94 [0.78-1.12],0.4812834765941804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,16064,141,0.93 [0.78-1.11],0.4200947780150559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,18524,168,0.96 [0.84-1.10],0.5601460671353707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,15598,136,1.03 [0.82-1.28],0.8021350912048344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,15598,136,0.97 [0.64-1.46],0.8675048114322835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,18133,164,1.15 [0.85-1.56],0.3726944311928245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,15563,139,0.89 [0.69-1.13],0.3342747029930254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,15563,139,0.91 [0.61-1.38],0.66619197542793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,15598,136,0.86 [0.62-1.19],0.350552313740241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,18216,160,1.06 [0.73-1.54],0.7602091752837787
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,15563,139,0.99 [0.72-1.37],0.9687132449231974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,18530,168,1.12 [0.83-1.52],0.4409502010799432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,18440,167,1.10 [0.86-1.40],0.4616451165630167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,18617,166,0.98 [0.67-1.45],0.9320963334907434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,15598,136,0.85 [0.63-1.17],0.3193274680645687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,18216,160,1.24 [0.97-1.59],0.082014809536564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,15955,142,0.91 [0.63-1.30],0.6028409357952527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,18379,166,1.04 [0.80-1.35],0.7582211457999805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,18379,166,1.25 [0.80-1.97],0.3312909882701964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,16110,145,1.92 [1.08-3.40],0.0262215712359375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,16089,144,0.77 [0.42-1.40],0.3935197467697559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,16064,141,0.82 [0.64-1.05],0.1121036444199409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,15641,140,0.93 [0.79-1.09],0.3570041678314311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,15563,139,0.91 [0.73-1.13],0.3737543543333274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,18133,164,0.89 [0.70-1.14],0.3664883139082667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,15529,136,0.74 [0.44-1.25],0.2621393675324917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,16036,144,0.94 [0.78-1.13],0.500686732061191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,18107,161,0.94 [0.74-1.20],0.6335784941277005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,18574,169,1.07 [0.88-1.30],0.489853935816762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,15563,139,0.96 [0.67-1.37],0.8253315045464935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,15563,139,1.02 [0.61-1.69],0.9440733109578574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,15563,139,0.77 [0.48-1.23],0.2720126715206216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,15529,136,0.98 [0.66-1.45],0.910096471474388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,15563,139,1.04 [0.81-1.34],0.7333469409815428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",15563,139,0.89 [0.62-1.26],0.5026360986483498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",18589,167,0.94 [0.83-1.07],0.3399422495481778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",18133,164,0.82 [0.57-1.17],0.2675502124478109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,18107,161,1.08 [0.77-1.52],0.6515692907083555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,18440,167,0.82 [0.47-1.44],0.4896363245532315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,18105,164,0.91 [0.73-1.12],0.3753607924354347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,15641,140,0.89 [0.70-1.12],0.3104171032440392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,15563,139,1.02 [0.86-1.21],0.8452246154485374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,16036,144,1.63 [1.15-2.33],0.0065774737653071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",16113,144,0.46 [0.18-1.19],0.1103585557261134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,18133,164,0.94 [0.77-1.13],0.4921120429472716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,15598,136,0.84 [0.70-1.02],0.0752320492635834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,16064,141,0.86 [0.60-1.23],0.4072089234043997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,16058,142,0.91 [0.70-1.18],0.4655924389251803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,18524,168,0.94 [0.82-1.09],0.4317010884633675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,18617,166,1.56 [0.95-2.57],0.0786023553854273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,16064,141,0.91 [0.67-1.22],0.5239079011211747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,17984,159,1.17 [0.99-1.38],0.060314378533962
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,16113,144,1.67 [1.37-2.03],2.799596182115364e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,15563,139,0.57 [0.25-1.31],0.1865008896704175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",15641,140,0.84 [0.54-1.30],0.4369471978310084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",18589,167,2.64 [1.65-4.22],4.868354635050197e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",18530,168,0.94 [0.53-1.65],0.8170561539360032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,15604,137,1.25 [0.75-2.08],0.3924538698147686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,18524,168,0.99 [0.82-1.19],0.9024990369915362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,18344,165,1.06 [0.75-1.50],0.7561651628825823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,15604,137,1.04 [0.75-1.45],0.811893565490718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,18197,158,1.23 [0.84-1.80],0.2862353830715551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,18107,161,1.18 [0.96-1.46],0.1195867059782265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,18107,161,2.22 [1.49-3.32],9.296905171616162e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,18524,168,0.99 [0.87-1.13],0.9107386752322532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,16058,142,1.26 [1.05-1.51],0.0124546679926995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,15673,134,1.10 [0.93-1.31],0.2683633171881867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,18103,164,1.02 [0.87-1.18],0.8375415980757832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,18530,168,1.15 [0.66-2.02],0.623110349166006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,18379,166,0.96 [0.65-1.43],0.8485337245514998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",16089,144,0.97 [0.57-1.65],0.9085261005651796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",15598,136,0.88 [0.63-1.25],0.4798222927436419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,15812,142,0.68 [0.37-1.23],0.2010938148701393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,16036,144,1.83 [1.57-2.12],3.546781195099788e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,16058,142,0.88 [0.75-1.04],0.1305468539636234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",18524,168,0.97 [0.70-1.34],0.8356204713482858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,15604,137,1.21 [0.95-1.55],0.1229981333699058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,15529,136,1.04 [0.81-1.33],0.7596339867229618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,16032,144,0.83 [0.57-1.22],0.3457069225988251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,18524,168,0.98 [0.85-1.14],0.8357305067269434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,16098,144,0.90 [0.75-1.08],0.2659993590250958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,15641,140,1.05 [0.80-1.38],0.73134458274319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,15529,136,0.86 [0.58-1.29],0.4700875623756916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,16098,144,0.89 [0.74-1.07],0.2215246851377429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,18081,161,1.13 [1.00-1.27],0.0430103791889367
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,15598,136,0.81 [0.63-1.05],0.1124542230948557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,15563,139,0.82 [0.44-1.53],0.5389352289462523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,18524,168,0.81 [0.65-1.00],0.0490867668882934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,18530,168,0.92 [0.79-1.07],0.2673799827404076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,18107,161,1.00 [0.80-1.25],0.99602298406527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,18759,168,1.37 [0.89-2.13],0.15618174035639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,15604,137,1.87 [1.41-2.46],1.04579065678729e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,15598,136,1.04 [0.84-1.29],0.7321061394957575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,16058,142,0.77 [0.51-1.17],0.2188309241280185
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,18530,168,1.03 [0.84-1.26],0.7668308289250377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,15738,143,0.95 [0.54-1.67],0.851394662304519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,18344,165,0.90 [0.67-1.22],0.5128379592543719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,18167,158,0.91 [0.63-1.30],0.5988702772079189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,15738,143,0.86 [0.42-1.76],0.6798492669964106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,16089,144,0.69 [0.42-1.13],0.1429746842582248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,15604,137,1.16 [0.80-1.67],0.4313619121241339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,18197,158,1.18 [0.64-2.19],0.5886072939574717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,15598,136,0.92 [0.67-1.27],0.6187481316281038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,15641,140,0.93 [0.69-1.27],0.6657887649985976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,15095,134,1.06 [0.91-1.24],0.4290039992072471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,18502,167,1.15 [0.93-1.42],0.2013968907300306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,16061,144,1.01 [0.78-1.30],0.9448050719317808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,15874,144,0.97 [0.84-1.12],0.7033088519918675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,15807,138,0.97 [0.56-1.68],0.910798687897724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,15598,136,0.65 [0.38-1.13],0.1263388389958546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,15563,139,0.86 [0.59-1.25],0.4281945801200643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,15563,139,0.84 [0.53-1.32],0.4463933262194954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,18133,164,1.46 [1.09-1.96],0.0109570664102727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,15598,136,0.62 [0.38-1.01],0.0548212428899632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,16064,141,0.67 [0.41-1.08],0.099422298311635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSG,Basigin,18718,169,1.46 [0.74-2.90],0.2736416264942974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BSND,Barttin,15529,136,0.99 [0.60-1.62],0.9643374650782508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,18697,171,1.58 [1.08-2.30],0.01847661922371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,18697,171,1.31 [1.02-1.68],0.0321487622764278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,18107,161,0.96 [0.79-1.16],0.6620103604287269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,16113,144,0.83 [0.38-1.79],0.6366176252831728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,15529,136,0.97 [0.80-1.18],0.7545497369764708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,15999,144,1.13 [0.77-1.66],0.5342117880545469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,18589,167,2.61 [1.65-4.12],4.046006756173462e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,18524,168,1.81 [1.33-2.48],0.0001952992432471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,15529,136,0.80 [0.49-1.29],0.361301182324887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,18133,164,1.19 [0.98-1.43],0.0730784192302377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,15563,139,0.81 [0.48-1.39],0.4456068656504136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,18660,169,4.09 [2.51-6.66],1.5243963941705382e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",16064,141,0.96 [0.75-1.22],0.7196375702331377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,15604,137,0.96 [0.65-1.42],0.8477039264442138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,18617,166,0.94 [0.68-1.30],0.6984490699837442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,15738,143,0.96 [0.61-1.51],0.8605883863230404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,16064,141,0.87 [0.51-1.47],0.6020770617441089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,15714,143,0.93 [0.67-1.29],0.6760120104093152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,16113,144,0.89 [0.35-2.25],0.8015239560037315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,16078,144,3.39 [1.47-7.82],0.0041494252355327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,16113,144,1.88 [0.92-3.85],0.0833864441561922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2,Complement C2,18594,165,0.85 [0.47-1.52],0.578857387979383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,18105,164,1.15 [0.85-1.56],0.3716823141215666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,15673,134,0.92 [0.68-1.26],0.6147246479033066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C3,Complement C3,15296,136,0.72 [0.46-1.11],0.1320294039213804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,18574,169,0.90 [0.63-1.30],0.5882288884464607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C5,Complement C5,16113,144,1.14 [0.39-3.36],0.8094662967609882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,15730,140,1.85 [1.12-3.08],0.0171348216270296
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,16058,142,1.51 [0.93-2.43],0.0921081003240594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,16113,144,0.90 [0.53-1.53],0.7077303926424826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,16110,145,1.50 [1.12-1.99],0.0058291211681605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,16036,144,1.00 [0.82-1.22],0.9845766901343636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,18165,162,0.98 [0.77-1.25],0.8591474974005072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,18107,161,0.90 [0.54-1.48],0.6685573958336112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,18440,167,1.07 [0.70-1.64],0.7544529797808407
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,18305,165,0.91 [0.80-1.03],0.1424580436982421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,18701,165,0.90 [0.61-1.32],0.5886927211414843
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,18471,167,0.97 [0.79-1.18],0.7330050274217295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,18734,168,1.10 [0.88-1.37],0.4116718867916673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,18759,168,0.90 [0.51-1.58],0.7180140520642658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",18197,158,1.05 [0.90-1.23],0.5007110717332259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,18472,168,1.02 [0.82-1.27],0.8827811869648149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,15807,138,1.01 [0.62-1.62],0.9802372111673158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,15604,137,1.12 [0.62-2.05],0.7017548491134082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,18701,165,1.00 [0.75-1.34],0.9964150348511172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,15673,134,0.94 [0.72-1.22],0.619772558667038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,15598,136,0.73 [0.42-1.29],0.286159699694824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,15563,139,0.68 [0.45-1.00],0.0528068324526084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,15598,136,0.87 [0.64-1.16],0.3420909527216568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,16064,141,0.91 [0.75-1.10],0.3317926963636053
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,15710,142,0.93 [0.80-1.09],0.3744057335586729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,15673,134,1.13 [0.76-1.67],0.543142927564148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,18440,167,0.93 [0.69-1.26],0.6529759630131329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,18133,164,1.02 [0.63-1.66],0.933291585577951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,18351,166,1.03 [0.84-1.26],0.776457500757441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,16058,142,0.89 [0.58-1.36],0.5794630936023696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,18647,165,0.96 [0.84-1.10],0.5350520397962516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,15641,140,1.03 [0.83-1.29],0.7583971263546222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,15563,139,0.72 [0.44-1.20],0.2067512221789728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,18107,161,1.37 [1.02-1.82],0.0335027770330915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,15673,134,0.73 [0.51-1.04],0.0804100447774718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,16064,141,0.88 [0.76-1.03],0.119384576845594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,18465,166,3.73 [1.90-7.31],0.0001263083447862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,18414,164,1.22 [0.98-1.53],0.0782078144678469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,16032,144,1.27 [0.88-1.84],0.2037963026493784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,16058,142,0.95 [0.79-1.13],0.5629410864693511
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,18133,164,0.87 [0.66-1.16],0.3476799739048583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,15673,134,1.03 [0.70-1.53],0.8763803876871175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,18133,164,1.10 [0.91-1.33],0.3091161340788641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,18133,164,0.96 [0.79-1.17],0.6985636973591598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,18524,168,0.90 [0.73-1.10],0.2968359599530408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,18759,168,0.93 [0.80-1.09],0.3604878768210294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,15807,138,0.92 [0.82-1.02],0.1244836646828542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,16058,142,0.92 [0.76-1.12],0.3939099739263657
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,18652,165,1.00 [0.80-1.24],0.9756479528338496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,15604,137,0.84 [0.63-1.10],0.2086406712140017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,15563,139,0.67 [0.43-1.04],0.0761925334543981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CAT,Catalase,15876,143,0.95 [0.71-1.29],0.7591950738153638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,18507,165,1.06 [0.88-1.27],0.5392755860957874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,15598,136,0.91 [0.74-1.11],0.3503817141607717
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,18701,165,0.56 [0.36-0.86],0.0078826617859019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,15641,140,1.16 [0.86-1.56],0.3319368337225127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,15563,139,1.00 [0.66-1.52],0.9988418121151816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,18379,166,0.99 [0.82-1.19],0.8904299662467154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,16058,142,1.04 [0.79-1.38],0.7796113183312586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,16032,144,0.99 [0.71-1.37],0.9342127712523944
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,15673,134,0.66 [0.38-1.16],0.1483939911569416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,16064,141,1.05 [0.86-1.29],0.6236884463976327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,18528,166,1.07 [0.72-1.58],0.7319722666581041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,15641,140,1.03 [0.79-1.34],0.8198568707324758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,18751,169,1.22 [0.85-1.74],0.2916784699673532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,18724,169,1.03 [0.84-1.25],0.8053904322428156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,18501,163,1.53 [1.15-2.05],0.003949861641426
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,18759,168,1.21 [0.90-1.64],0.2057769697211909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,18759,168,1.04 [0.80-1.36],0.7605407133759694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,18469,165,1.07 [0.93-1.25],0.3480621118534828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,18301,162,1.15 [0.96-1.37],0.1278034981366237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,18697,171,1.06 [0.95-1.17],0.2843910932392337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,18344,165,1.09 [0.84-1.41],0.5338415699718299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,18751,169,1.00 [0.86-1.18],0.9544656799418576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,18589,167,1.49 [1.11-1.99],0.0071880939949287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,18310,165,1.31 [1.01-1.68],0.0379921767273782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,18589,167,1.30 [0.94-1.80],0.1128999680664392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,18567,166,1.31 [1.11-1.54],0.0011145905409482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,18751,169,1.04 [0.79-1.38],0.7665421684943329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,18524,168,1.07 [0.93-1.23],0.3501386895731612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,18528,166,0.96 [0.77-1.20],0.738543252316169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,18461,168,1.02 [0.81-1.28],0.8714892645413834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,18524,168,1.36 [1.19-1.56],5.423348616968655e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,18530,166,1.29 [1.10-1.51],0.0015229918466866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,18617,166,0.85 [0.75-0.98],0.0212301195780151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,18524,168,1.13 [0.90-1.41],0.305436254558092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,18675,165,1.23 [0.98-1.55],0.0710839778415245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,18414,167,0.84 [0.70-1.02],0.0746056889407404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,18512,164,0.88 [0.69-1.13],0.3098927338515753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,18722,168,1.41 [0.94-2.10],0.0940410188109516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,18701,165,0.93 [0.64-1.33],0.6782439339849922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,18530,168,1.05 [0.73-1.51],0.7788343588553344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,15807,138,1.30 [0.82-2.05],0.2601401175831194
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,15604,137,1.03 [0.87-1.22],0.7424427871113168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,18379,166,1.02 [0.76-1.36],0.9173992521564968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,18107,161,0.94 [0.68-1.30],0.7125783814560352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,16036,144,0.90 [0.63-1.29],0.5809980058932248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,18530,168,0.86 [0.57-1.29],0.4651492162076494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,18188,161,1.49 [1.07-2.08],0.0186217058921323
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,18751,169,1.60 [1.22-2.09],0.0006516153335662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,18617,166,1.47 [1.08-2.00],0.0141453096910037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,18530,168,1.00 [0.59-1.68],0.9867951788694164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,15673,134,1.01 [0.65-1.59],0.9491262451101724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,18498,168,1.12 [1.00-1.25],0.050669539937377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,18574,169,3.05 [1.74-5.35],9.735342451255384e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,15563,139,1.23 [0.88-1.72],0.2224902413305952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,18524,168,2.10 [1.35-3.26],0.0009426737947456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,18458,168,1.10 [0.75-1.61],0.6230497899575804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,18096,162,0.86 [0.60-1.23],0.4129195738878721
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,18578,168,0.71 [0.49-1.01],0.0564496777003152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,18751,169,2.77 [2.21-3.47],5.247327527994316e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,15604,137,0.91 [0.61-1.35],0.6323299364215017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,18751,169,1.50 [0.93-2.43],0.0970786678881528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,16098,144,1.12 [0.75-1.67],0.5710301942812471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,18574,169,3.58 [2.78-4.61],6.911185573363639e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,18379,166,2.13 [1.52-2.98],1.1179967666059463e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,18498,166,1.24 [0.84-1.84],0.273563238944871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,18107,161,2.35 [1.97-2.79],5.1679272765579e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,18528,166,0.87 [0.70-1.09],0.2212265446433406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,15738,143,2.39 [1.46-3.89],0.0004960505533436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,18697,171,1.96 [1.35-2.83],0.000350571652006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,18647,165,2.29 [1.70-3.07],3.8627386335669664e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,18701,165,1.61 [1.24-2.09],0.0003341320640242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,18530,168,1.00 [0.69-1.45],0.9869358804366072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,18440,167,1.49 [0.97-2.28],0.06954286504922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,18574,169,1.05 [0.88-1.25],0.5754236857892192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,18637,171,0.86 [0.49-1.52],0.6103837279227682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,15604,137,0.75 [0.52-1.09],0.1328513979323344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,18440,167,1.18 [0.77-1.80],0.4445041140058033
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,15598,136,0.89 [0.53-1.49],0.6524827095940773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,15807,138,1.17 [0.80-1.71],0.4256000914771701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,15604,137,1.02 [0.85-1.22],0.8395004647591867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,18492,168,1.65 [1.17-2.32],0.0042217877220029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,18508,165,1.21 [0.92-1.58],0.1696789856930391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,18751,169,0.86 [0.72-1.01],0.0710173698139179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,18446,162,1.36 [0.85-2.17],0.1957297022271495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,18567,166,4.43 [2.93-6.68],1.4015014763896045e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,18675,165,3.27 [2.61-4.09],6.9876703666725635e-25
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,17904,159,1.21 [0.72-2.04],0.4773884599438486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,18464,166,1.54 [0.70-3.39],0.2793896860100537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,17883,158,1.49 [0.83-2.69],0.1842155019065364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,16042,141,1.82 [1.31-2.53],0.0003359222209807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,18718,169,1.63 [1.25-2.11],0.0002671049954588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,18344,165,0.87 [0.66-1.14],0.300598665781615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,18434,164,0.92 [0.79-1.07],0.280668964681852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,15577,137,1.91 [1.43-2.55],1.265366331940265e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,18524,168,3.26 [2.57-4.14],2.9809355632832303e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,15738,143,4.82 [3.73-6.23],2.2242019343165577e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,18697,171,3.44 [2.45-4.81],6.967717005977836e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,18751,169,3.62 [2.99-4.38],1.2305303113007916e-39
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,16089,144,5.38 [4.03-7.19],4.440470395150911e-30
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,15807,138,0.73 [0.45-1.18],0.201818509313204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,18524,168,3.58 [2.55-5.01],1.4772221450671678e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,18524,168,0.75 [0.49-1.14],0.1759537312747271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,16036,144,2.98 [1.84-4.81],8.853307467910261e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,18697,171,1.40 [1.10-1.80],0.006972034606732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,17854,159,1.24 [0.79-1.95],0.357807740219754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,18530,168,1.19 [0.59-2.38],0.6299745013764431
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,18530,168,0.84 [0.48-1.47],0.5507996205960959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,16067,143,1.22 [0.89-1.67],0.2152907131238204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,16058,142,1.06 [0.53-2.12],0.8707021726165294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,15529,136,1.14 [0.91-1.44],0.2549390778211661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,15529,136,1.19 [0.82-1.74],0.3678859026040978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,15998,144,0.91 [0.72-1.15],0.4256326349342211
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,18107,161,0.98 [0.78-1.24],0.8632419714526629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,18574,169,0.93 [0.79-1.09],0.3781352588034271
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,16036,144,0.93 [0.79-1.09],0.3531547610336456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,18379,166,1.35 [1.07-1.70],0.011575831946092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,17930,162,0.89 [0.62-1.29],0.5436903693875829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,18669,171,0.90 [0.74-1.10],0.3083604806961083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,18528,166,0.92 [0.75-1.13],0.4331576711663603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,18528,166,1.25 [0.85-1.85],0.2537984172574742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,15807,138,0.77 [0.42-1.43],0.40542235703544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,16058,142,0.95 [0.51-1.74],0.8563240462117764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,18697,171,2.37 [1.69-3.32],5.761062540514749e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,15598,136,0.95 [0.66-1.37],0.7874812602535444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,18759,168,1.13 [0.72-1.77],0.5941390122407381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,18528,166,1.19 [0.84-1.71],0.331085883410797
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,18133,164,1.08 [0.79-1.49],0.624574162324838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,18440,167,1.01 [0.82-1.25],0.9142900932938728
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,18528,166,0.79 [0.56-1.11],0.1673474972416544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,15529,136,1.09 [0.69-1.72],0.7136153834687204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,16064,141,0.75 [0.55-1.01],0.0608920223473129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,15598,136,0.89 [0.63-1.25],0.4881303706452314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,18440,167,0.98 [0.86-1.11],0.7402872173275918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,18440,167,0.99 [0.86-1.15],0.922396704433322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,18440,167,0.77 [0.50-1.18],0.2313652755924031
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,18528,166,0.53 [0.32-0.87],0.0113918229244338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,18698,167,1.18 [0.86-1.62],0.2928013682104681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,18547,169,1.04 [0.56-1.92],0.909697448784238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,16036,144,1.07 [0.88-1.30],0.4872250737937164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,15807,138,0.90 [0.69-1.17],0.4163538994759354
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,16036,144,1.78 [1.26-2.52],0.0010164065122535
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,15807,138,1.17 [0.83-1.66],0.3647255389677009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,18524,168,1.24 [1.06-1.44],0.0056486060591008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,18107,161,0.94 [0.69-1.28],0.7064629735751752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,17871,160,1.01 [0.80-1.28],0.9319267158864808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,16098,144,1.30 [0.90-1.88],0.1588504176035608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,18197,158,1.35 [1.03-1.76],0.0309354876803052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,15604,137,1.30 [0.91-1.88],0.150853777004146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,18197,158,1.34 [0.95-1.88],0.0977744427808395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,16098,144,1.10 [0.86-1.42],0.4507685388651333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,18728,168,1.05 [0.84-1.31],0.6855752239129554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,15738,143,0.77 [0.43-1.35],0.3586323131899355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,15604,137,1.17 [0.70-1.95],0.5435743984572171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,15598,136,0.89 [0.65-1.22],0.4691298029667818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,15807,138,1.24 [0.94-1.64],0.1246109450526435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,15807,138,1.06 [0.85-1.32],0.6032062569141441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,15563,139,1.14 [0.83-1.55],0.4133354530659842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,15529,136,0.80 [0.52-1.22],0.2971870674933997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,18216,160,1.16 [0.97-1.39],0.1047611701992007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,15641,140,0.95 [0.76-1.18],0.6357515671303482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,18107,161,1.05 [0.87-1.26],0.6375814553187823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,15807,138,0.76 [0.53-1.09],0.1316991396626656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,15529,136,0.93 [0.59-1.47],0.7625639851228462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,18057,158,0.99 [0.81-1.22],0.9353861827540416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,18107,161,1.09 [0.88-1.35],0.4385295033459379
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,18133,164,0.86 [0.68-1.08],0.1942567797742254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,18574,168,0.78 [0.66-0.92],0.004154850950384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,18440,167,0.78 [0.60-1.01],0.0580034391425488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,18440,167,0.67 [0.53-0.85],0.0007288515075632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,18133,164,0.97 [0.79-1.19],0.7798938038281681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,16036,144,0.91 [0.74-1.12],0.3789763885962108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,15839,140,1.30 [0.79-2.15],0.3037087295592142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,18107,161,1.31 [1.01-1.71],0.0449574179346743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,16113,144,0.78 [0.35-1.76],0.5554443362555844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,15206,135,1.44 [0.71-2.95],0.3137169795282591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,15999,144,1.83 [1.31-2.56],0.0004121727082862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,16079,144,1.43 [1.12-1.82],0.0035474991310628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,15908,141,1.72 [1.14-2.60],0.0099378674644697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,16113,144,1.11 [0.49-2.53],0.8014060786555011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CFP,Properdin,16113,144,1.06 [0.52-2.16],0.878434282423898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,18530,168,1.39 [1.14-1.70],0.0010921038680817
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,16110,145,1.09 [0.71-1.69],0.6872361339502606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,15673,134,1.09 [0.72-1.65],0.6959055167980666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,18528,166,0.99 [0.72-1.36],0.9437599791463434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,18107,161,0.99 [0.78-1.26],0.9343800333915152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,15738,143,0.68 [0.48-0.95],0.0254170363443369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",16058,142,1.58 [1.15-2.18],0.0046953796795813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,16032,144,1.73 [1.10-2.71],0.01710272939697
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,18197,158,0.96 [0.62-1.49],0.8552847486419994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,16098,144,1.24 [1.06-1.45],0.0061437230887884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,18646,170,1.15 [0.83-1.60],0.3872419204069371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,18148,159,1.16 [0.99-1.36],0.0679783256638473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,18616,167,1.05 [0.96-1.16],0.2978619551943782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,18590,166,1.29 [0.82-2.02],0.2673709477784429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,15673,134,0.84 [0.64-1.12],0.243906172009635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,18379,166,0.93 [0.78-1.11],0.4130205089593746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,16089,144,0.80 [0.60-1.06],0.1207668270521645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,15598,136,0.87 [0.68-1.12],0.2761312246984166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,18567,166,1.41 [0.92-2.16],0.114206551364895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,18528,166,1.04 [0.77-1.40],0.8138131663809687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,15673,134,0.91 [0.56-1.48],0.7132926890537021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,18574,169,0.91 [0.73-1.14],0.4116983052002791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,16098,144,1.17 [0.87-1.58],0.2966234776161021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,15807,138,0.95 [0.65-1.40],0.812379772965877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,16036,144,0.94 [0.80-1.11],0.4827627491527779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,15673,134,1.49 [1.13-1.98],0.0048727825787372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,18659,168,2.15 [1.52-3.04],1.3085120302697074e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,16098,144,1.56 [1.19-2.06],0.001326790467972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",18444,165,0.80 [0.66-0.97],0.0263345473435182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,15529,136,0.85 [0.66-1.09],0.1881070070423227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,18499,166,0.89 [0.72-1.10],0.285962340187156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,18379,166,1.35 [0.93-1.98],0.1183203807131611
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,18502,168,1.15 [0.87-1.53],0.3267732430519472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,15604,137,2.86 [1.78-4.57],1.2106305356118062e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,18530,168,1.49 [0.98-2.25],0.0603654561650321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,18197,158,1.21 [0.80-1.84],0.3700442992577973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,18697,171,0.96 [0.84-1.11],0.5911125088664602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,15673,134,0.85 [0.59-1.23],0.3999732563985618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,15750,139,0.54 [0.24-1.21],0.1363526482018451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,18524,168,0.88 [0.60-1.28],0.498291522008682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,18524,168,1.21 [0.91-1.60],0.1947741234755376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,18524,168,1.15 [0.93-1.43],0.2054837845635959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,18524,168,1.28 [0.85-1.93],0.2296972404532342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,16076,144,0.76 [0.55-1.06],0.1074103539834935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,18467,165,2.00 [1.31-3.06],0.0013599625386885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,18107,161,1.93 [1.49-2.49],5.580205297840252e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,18751,169,1.55 [1.16-2.08],0.0032514265304659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,15673,134,1.08 [0.75-1.54],0.6863013738400947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,15673,134,1.12 [0.68-1.85],0.6541948338748251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,15529,136,0.90 [0.61-1.30],0.565264405616866
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,18524,168,0.99 [0.88-1.12],0.8879729503625775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,18701,165,1.42 [0.76-2.66],0.2680105428981142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,15673,134,1.08 [0.68-1.73],0.7455605968465318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",18351,166,1.01 [0.87-1.16],0.9410849348716166
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,18492,168,1.14 [0.94-1.37],0.1734373391390328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,18105,164,0.96 [0.65-1.42],0.8331390044760205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,18133,164,1.05 [0.81-1.36],0.7217149572332625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,18751,169,1.10 [0.79-1.55],0.57180444169368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,16058,142,2.13 [1.36-3.33],0.0009614225164238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,18197,158,0.90 [0.65-1.23],0.4960900903572186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,16113,144,0.90 [0.47-1.73],0.7551009041350293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,18494,166,0.80 [0.58-1.09],0.1539711889231136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,16089,144,0.89 [0.74-1.06],0.1918723222436911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,16032,144,0.88 [0.72-1.07],0.1921468867224712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,18617,166,0.73 [0.55-0.97],0.0274824034267506
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,15598,136,0.75 [0.50-1.11],0.1459326630981085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",15612,139,0.90 [0.73-1.11],0.3043207533774105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,18197,158,0.88 [0.67-1.15],0.3385857677430848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,18440,167,0.93 [0.77-1.11],0.4008181273712607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNST,Consortin,18528,166,0.93 [0.82-1.05],0.2276419984238492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,15598,136,1.10 [0.68-1.76],0.7034979381949391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,18759,168,1.11 [0.67-1.85],0.6895764869672598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,18701,165,1.08 [0.79-1.47],0.6398619356548043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,18530,168,0.52 [0.32-0.83],0.0063366307663425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,18530,168,0.55 [0.31-0.98],0.04274815285634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,18582,171,0.84 [0.58-1.22],0.3647281863589141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,18524,168,1.16 [0.84-1.59],0.3592163063915278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,15673,134,0.97 [0.82-1.14],0.6906567674890404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,16089,144,1.33 [0.95-1.86],0.0968681656737444
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,16098,144,0.80 [0.44-1.46],0.468476938752509
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,18602,166,1.81 [1.01-3.24],0.0450849668237388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,18759,168,0.66 [0.36-1.20],0.174220315386557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,16036,144,0.93 [0.71-1.22],0.5999314353061531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,15673,134,0.99 [0.81-1.22],0.9578413056290312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,15641,140,0.81 [0.65-1.00],0.052929329029114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,16098,144,1.15 [0.58-2.28],0.6817724020773319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,18528,166,1.75 [1.26-2.43],0.0008838794479481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,15777,137,0.86 [0.65-1.15],0.3082520723014029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,15738,143,1.00 [0.66-1.51],0.9907944699412718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,18759,168,1.59 [1.10-2.28],0.0127606215187371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,18524,168,0.91 [0.66-1.24],0.5412378000767808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,15807,138,0.97 [0.66-1.42],0.8697487973720482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,18498,166,1.79 [1.09-2.95],0.0215998964284283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,15641,140,0.97 [0.74-1.28],0.8393596881643592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,16032,144,1.17 [0.81-1.69],0.4044469562579851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,18354,163,0.99 [0.65-1.51],0.9662507510663794
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,17996,154,0.99 [0.83-1.18],0.922423499167204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',15563,139,0.78 [0.52-1.15],0.2053682728303565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,18133,164,0.91 [0.67-1.25],0.5749266703635092
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",15641,140,1.00 [0.68-1.46],0.9991357672218376
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,18161,161,1.02 [0.87-1.19],0.7897551709664583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,15598,136,1.24 [0.82-1.86],0.3092000086217594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",18440,167,1.03 [0.84-1.25],0.8016470596139893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,16089,144,1.08 [0.67-1.74],0.7644328549499657
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,18759,168,1.05 [0.85-1.29],0.671872090900058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,18643,170,1.16 [0.96-1.42],0.1274581378779648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,15434,139,1.05 [0.71-1.53],0.818384030574549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,18759,168,1.15 [0.93-1.42],0.2003490431688542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,16086,142,0.88 [0.43-1.80],0.7280983598847757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,18541,165,0.76 [0.55-1.05],0.1013670925576137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,15529,136,0.79 [0.45-1.38],0.4125915249321285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,18610,170,0.84 [0.56-1.24],0.3798190639355008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",15604,137,0.90 [0.48-1.67],0.7320204794341011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,18697,171,1.06 [0.86-1.29],0.5981294196784099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,16071,144,1.19 [0.77-1.87],0.4337203692593037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,15563,139,0.77 [0.49-1.22],0.2708976315526076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,18666,165,1.52 [1.07-2.16],0.0185280751105222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,18574,169,0.94 [0.77-1.14],0.5321427984242867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,16089,144,1.21 [0.64-2.26],0.5548210340387326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,16053,144,2.21 [1.44-3.39],0.0002990804038661
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,18617,166,2.10 [1.59-2.78],2.275448848533689e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,18107,161,0.99 [0.84-1.17],0.9426779865348844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,18351,166,0.96 [0.80-1.15],0.6551474958139014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,15529,136,0.76 [0.54-1.08],0.1302876366044312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,15529,136,0.86 [0.45-1.65],0.6592514040832105
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,18287,167,1.02 [0.73-1.43],0.918903893952756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,15738,143,1.13 [0.73-1.76],0.586546479545605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,18567,166,1.15 [0.89-1.49],0.2976455293031093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,18081,161,1.13 [0.96-1.32],0.1505446033076429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,18498,166,1.19 [0.72-1.98],0.4928953277803857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,18197,158,1.08 [0.87-1.35],0.4809326128392143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,18589,167,2.26 [1.17-4.36],0.0147227988897476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,18379,166,1.19 [0.84-1.69],0.3201990879777585
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,18701,165,1.02 [0.79-1.31],0.8950996676326816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,15956,145,0.96 [0.53-1.73],0.8900379195695346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,18533,166,0.97 [0.85-1.10],0.61249523659004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,18589,167,1.30 [0.75-2.27],0.3469717152310519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,18001,159,1.04 [0.84-1.28],0.7316001608805599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,18759,168,0.78 [0.51-1.21],0.2682511307062732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,18379,166,3.45 [2.70-4.39],1.3148122998172857e-23
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,15673,134,0.98 [0.70-1.38],0.9168217988437356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,18197,158,1.07 [0.95-1.21],0.2512083780586859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,16089,144,0.94 [0.73-1.20],0.625703557034708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,16058,142,0.92 [0.72-1.18],0.5164597788762144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,16058,142,0.93 [0.79-1.10],0.4240415340577435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,15598,136,1.02 [0.81-1.28],0.8743531335691169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,15641,140,0.89 [0.75-1.07],0.232307492861706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,15563,139,1.01 [0.88-1.16],0.8618929820482315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,18589,167,2.77 [1.72-4.45],2.7885228048789594e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,16110,145,1.62 [1.14-2.30],0.0071077492583631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,15563,139,0.60 [0.37-0.98],0.0422341056747094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,18379,166,1.27 [1.04-1.56],0.0209807806513566
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,15604,137,1.56 [1.05-2.32],0.0269212469108736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,18216,160,1.37 [1.04-1.79],0.0232694993069056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,15604,137,1.43 [0.86-2.36],0.1633425147177867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,16110,145,1.05 [0.61-1.82],0.8523598195485893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,15604,137,1.11 [0.87-1.43],0.4078811120790752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,16064,141,0.82 [0.57-1.18],0.2827304740048315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,16098,144,1.12 [0.69-1.81],0.6499861269161773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,15598,136,0.93 [0.66-1.31],0.6779533632982901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,15563,139,1.17 [1.02-1.35],0.0268583483447251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,13978,129,0.89 [0.75-1.06],0.2039368220511897
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,18582,166,1.66 [1.05-2.63],0.030655751205782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,18147,164,1.12 [0.88-1.44],0.35261243860356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,18048,159,0.95 [0.71-1.26],0.7079069696725993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,18530,166,1.12 [0.98-1.27],0.0857046185814515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,18272,160,1.33 [0.97-1.81],0.074810797266689
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,15780,138,0.91 [0.65-1.28],0.5974648485727316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,15887,143,1.19 [0.65-2.20],0.5720363290702708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,18197,158,0.90 [0.76-1.07],0.219355709113285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,16098,144,1.32 [0.76-2.31],0.3293869714315742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,16098,144,1.01 [0.61-1.69],0.9594413747119618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,15598,136,0.56 [0.29-1.06],0.073049470019802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,18530,168,1.14 [0.90-1.43],0.2689198668928665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,18498,166,1.06 [0.86-1.30],0.6090423962193041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,16058,142,1.01 [0.81-1.27],0.9000425057553736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,18534,166,1.36 [1.06-1.75],0.0150854009201687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,18462,164,1.03 [0.76-1.40],0.8517586479510872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,17335,150,1.17 [0.83-1.64],0.3701994668872171
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,15738,143,1.07 [0.79-1.46],0.6421729408961907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,18574,169,1.04 [0.74-1.46],0.8373583960021244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,18133,156,1.20 [0.99-1.45],0.0577461870449244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,18528,166,2.50 [1.48-4.22],0.0006298288119894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,18751,169,1.57 [1.03-2.39],0.035163621595366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,14624,131,1.32 [0.65-2.67],0.4482323558737289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,18632,165,0.58 [0.40-0.84],0.0036909632947807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,18557,164,1.68 [1.10-2.58],0.0169143639935589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,15673,134,1.08 [0.73-1.61],0.7041429487522683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,15945,144,1.28 [1.05-1.56],0.0143104886488381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,18379,166,1.36 [0.90-2.05],0.1405201645862278
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,18524,168,1.16 [0.87-1.53],0.3102502372176722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,18477,165,0.95 [0.82-1.11],0.5411366301472634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,18589,167,1.30 [1.08-1.57],0.0053342529047071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,18697,171,1.27 [1.09-1.46],0.0014246776176906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,18216,160,1.28 [0.90-1.83],0.1693038288163733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,18697,171,1.70 [1.56-1.85],3.856602613081957e-33
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,18216,160,0.98 [0.76-1.26],0.8932687393565635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,18728,168,0.55 [0.30-1.00],0.0513898799676994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,18751,169,1.15 [0.84-1.57],0.3865419315059992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,18508,165,0.88 [0.77-1.02],0.0842584928242599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,18466,166,0.87 [0.77-0.98],0.0243553573874034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,18751,169,1.08 [0.90-1.29],0.4209262379756896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,18421,165,1.08 [0.89-1.31],0.4217178511736494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,18589,167,1.76 [1.52-2.05],1.0300368279006877e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,15529,136,1.04 [0.83-1.31],0.704454308963526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,15870,142,1.29 [0.98-1.71],0.0689409987948905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",15563,139,1.00 [0.82-1.21],0.9769691112918752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,15529,136,0.93 [0.73-1.18],0.5505063453552828
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,16098,144,0.70 [0.37-1.32],0.2696231044560141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,15738,143,0.92 [0.76-1.12],0.4138138401969903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,18701,165,0.94 [0.84-1.07],0.3465457043756356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,18589,167,0.93 [0.69-1.24],0.625074963885522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,15604,137,1.00 [0.75-1.33],0.9866131533287412
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,15604,137,1.13 [0.87-1.48],0.3521361025363714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,18524,168,0.97 [0.87-1.09],0.6298388570285768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",18351,166,0.93 [0.77-1.13],0.467275520550635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,16088,144,1.06 [0.91-1.23],0.4381428359122707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,18442,167,0.99 [0.83-1.18],0.9082151777193428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,15604,137,0.92 [0.66-1.29],0.642084411508334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,18589,167,0.97 [0.83-1.12],0.650878534218207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",18574,169,1.33 [0.91-1.94],0.1452967265881047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,15673,134,0.97 [0.45-2.06],0.9318780177906963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,15529,136,0.78 [0.58-1.05],0.1033967557427727
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,15529,136,0.81 [0.46-1.40],0.4424746219897002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCN,Decorin,18197,158,1.42 [0.77-2.60],0.2572862353818938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,15738,143,0.92 [0.78-1.09],0.349895255541634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,18701,165,0.91 [0.74-1.13],0.4023465216848148
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,18440,167,0.98 [0.85-1.14],0.8228176442412608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,18133,164,0.91 [0.74-1.12],0.3723618988165648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,18528,166,3.56 [2.45-5.18],3.125139872982128e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,15598,136,0.99 [0.79-1.23],0.9220541473790336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,15529,136,0.85 [0.67-1.08],0.1861042689794762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,18574,169,0.85 [0.66-1.11],0.2299662733721088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,15563,139,1.09 [0.73-1.64],0.6734584532944694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",18440,167,0.95 [0.69-1.30],0.735317494342192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,18507,165,1.00 [0.74-1.34],0.9958848357471504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,16064,141,0.85 [0.67-1.09],0.2012945527089117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,15738,143,0.96 [0.78-1.19],0.7087125244195023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,18697,171,1.84 [1.05-3.24],0.0328477531081071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,16098,144,1.13 [0.77-1.64],0.5363998231316759
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,16036,144,1.14 [0.85-1.53],0.3885114920322913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,15673,134,0.77 [0.46-1.30],0.3301208130443626
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,15604,137,1.25 [0.68-2.31],0.4723962086417222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,15604,137,1.01 [0.75-1.36],0.954272941125495
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,15673,134,0.80 [0.50-1.29],0.3628766147198025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,18107,161,1.23 [1.00-1.52],0.0502092411257001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",18524,168,0.94 [0.81-1.08],0.3695357968395293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,18183,163,1.33 [1.07-1.67],0.0112541485616331
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,15495,135,0.94 [0.63-1.42],0.7700839967915247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,15598,136,0.76 [0.54-1.06],0.1051528658040975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,15598,136,1.01 [0.81-1.27],0.9325085480192687
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,15598,136,1.02 [0.76-1.36],0.9049184233525338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,18245,167,1.10 [1.00-1.21],0.0496990470074321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,15563,139,0.62 [0.39-0.99],0.0431075176720599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,15604,137,0.72 [0.53-0.99],0.046323012344939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,18751,169,0.98 [0.80-1.20],0.8407522397429665
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,15598,136,1.15 [0.81-1.63],0.4422084766659274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,15604,137,0.88 [0.64-1.20],0.407161948508032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,18216,160,0.87 [0.58-1.30],0.4987076224519258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,15563,139,0.88 [0.60-1.29],0.5214287551028474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,16032,144,1.63 [1.26-2.13],0.0002622705812936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,16058,142,0.79 [0.54-1.15],0.2167165970907745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",18467,165,0.90 [0.79-1.02],0.0853473581990352
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,15673,134,1.11 [0.75-1.62],0.6055769779548642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,15738,143,0.89 [0.50-1.57],0.676741954427351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,18697,171,0.97 [0.77-1.22],0.7871445378691276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,18759,168,0.87 [0.54-1.38],0.5485099920377677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,18346,166,1.02 [0.76-1.38],0.8927408505304947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,18440,167,1.08 [0.92-1.28],0.3423203517914917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,16058,142,0.83 [0.66-1.05],0.1265341526838055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,16064,141,1.04 [0.77-1.42],0.7879420728773676
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,18759,168,0.83 [0.65-1.05],0.1113582655192707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,18574,169,2.38 [1.56-3.62],5.306763508001373e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,15641,140,0.89 [0.70-1.13],0.3346223342127283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,15641,140,1.06 [0.76-1.48],0.7228222182533846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,15641,140,0.82 [0.62-1.08],0.1662845076178803
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,15529,136,1.12 [0.80-1.57],0.492067978301494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,18692,168,0.93 [0.79-1.10],0.4139857921972776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,16058,142,1.03 [0.82-1.28],0.8203666456905315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,18440,167,0.94 [0.80-1.11],0.4749217279989522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,16036,144,1.02 [0.80-1.31],0.8516831031517901
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,15738,143,0.78 [0.57-1.07],0.1177783334009996
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,15594,141,0.91 [0.75-1.10],0.3260110645735855
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,18197,158,0.90 [0.68-1.18],0.4384135081088056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,16058,142,0.80 [0.51-1.23],0.3054084961172916
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,15641,140,0.87 [0.71-1.06],0.1693782866614841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,16036,144,0.93 [0.76-1.15],0.5144687121767002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,18469,166,0.65 [0.38-1.10],0.1077013949964029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,15598,136,1.12 [0.95-1.34],0.1818491039816276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,16036,144,0.89 [0.77-1.01],0.0782102202881624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,16064,141,0.91 [0.67-1.24],0.5400485394995473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,18379,166,1.11 [0.88-1.38],0.3782224914707541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,16058,142,0.99 [0.74-1.31],0.9342193091076176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,18555,167,0.90 [0.69-1.18],0.4471066185363778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,15673,134,1.26 [0.89-1.79],0.1963742190230313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,15598,136,0.94 [0.81-1.10],0.4399229883593121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,16058,142,0.95 [0.84-1.06],0.3507790143581251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,18528,166,0.93 [0.83-1.04],0.2090182765476982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,18351,166,1.17 [0.87-1.58],0.3046319530891065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,18440,167,1.15 [0.73-1.81],0.5453087406650988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,18524,168,1.08 [0.74-1.56],0.7029196082042648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,18203,159,0.53 [0.32-0.89],0.0156154158541675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,18440,167,0.83 [0.55-1.24],0.360189442230465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,18389,166,1.06 [0.85-1.32],0.6130256671736292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,18759,168,1.18 [0.68-2.05],0.5529957267881414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,18650,165,1.24 [1.00-1.53],0.0472639032573703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,18379,166,1.32 [0.96-1.82],0.0873652919594345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,18440,167,0.92 [0.72-1.17],0.5026348594206027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,18300,167,2.36 [1.65-3.38],2.41695115589168e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,16064,141,1.28 [0.82-2.00],0.2737855351655245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,18530,168,1.21 [0.74-1.99],0.4529586765326857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,18642,165,1.41 [0.95-2.09],0.0860856085992618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,18375,167,0.97 [0.73-1.28],0.8151855555168597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,15738,143,0.88 [0.73-1.06],0.1812975864557359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,15994,144,1.45 [1.05-2.00],0.0235052894709554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,15673,134,1.01 [0.77-1.33],0.9407740223288832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,18440,167,2.24 [1.36-3.69],0.0014541875509992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,16089,144,0.89 [0.70-1.13],0.3235519383274315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,18197,158,0.80 [0.63-1.01],0.0618935287844244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,16032,144,0.63 [0.42-0.94],0.0242939432834136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,15673,134,1.05 [0.82-1.34],0.6877671098774865
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,18133,164,0.94 [0.79-1.11],0.456420479054539
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",16036,144,0.93 [0.80-1.09],0.3762133036242417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,16058,142,0.97 [0.68-1.39],0.8867357704311435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,16032,144,1.10 [0.80-1.51],0.5596037636389812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,15673,134,1.14 [0.93-1.38],0.204064738466992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,16032,144,1.07 [0.75-1.53],0.7147871365844526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,18379,166,0.98 [0.85-1.14],0.8178773628889179
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,18678,165,3.61 [2.37-5.49],1.8944906740563366e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,18133,164,0.80 [0.54-1.18],0.2584880307203193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",16089,144,1.10 [0.89-1.36],0.3591963583472767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",15641,140,0.93 [0.78-1.10],0.3878544274079075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,15563,139,0.92 [0.70-1.22],0.5663685385990593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,15687,138,1.14 [0.72-1.79],0.5736719576615854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,15598,136,0.72 [0.48-1.09],0.1178378492743504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,18701,165,1.84 [1.32-2.57],0.0003598507780428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,18524,168,0.83 [0.71-0.96],0.0145742785044005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,16032,144,0.84 [0.64-1.11],0.2182695518287816
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,15563,139,0.64 [0.38-1.10],0.1084621979555277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,16064,141,0.92 [0.72-1.18],0.5143625643692129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,18197,158,0.88 [0.58-1.33],0.5455847663892947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,15641,140,1.75 [1.02-3.00],0.0434205569643764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,15604,137,1.25 [0.91-1.70],0.1637313436741748
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,16089,144,0.99 [0.83-1.18],0.9312124033234178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,16036,144,1.66 [1.16-2.38],0.0057918648925924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,15807,138,0.78 [0.48-1.26],0.3097928538454484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,18587,166,0.99 [0.64-1.54],0.967058420238256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,16064,141,1.18 [0.76-1.82],0.4590044265948266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,18498,167,1.83 [1.18-2.85],0.0067393075879264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,18344,165,3.52 [2.52-4.92],1.954725103172421e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,15673,134,0.92 [0.67-1.26],0.6149777783086887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,18478,166,0.97 [0.85-1.10],0.600780393014961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,18107,161,1.45 [1.04-2.02],0.0266201323502134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,16036,144,0.88 [0.51-1.49],0.6222895242799009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,18759,168,0.45 [0.19-1.05],0.0640832328299893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,18524,168,1.26 [1.04-1.52],0.0198677580204683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,16089,144,0.87 [0.70-1.09],0.2219055318597418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,15641,140,0.86 [0.75-0.98],0.0264392833696753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",16058,142,0.91 [0.67-1.24],0.5594817854276202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",15980,144,0.96 [0.83-1.11],0.59232232665719
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,15563,139,0.88 [0.67-1.15],0.3358158629626256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,15641,140,0.99 [0.67-1.45],0.9502331076071772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,18379,166,0.94 [0.73-1.20],0.6086917765358617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,15604,137,0.87 [0.72-1.05],0.1553915226917534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,18528,166,0.98 [0.79-1.21],0.8176141946708915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,18751,169,0.96 [0.84-1.10],0.5496224326316322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,16064,141,0.80 [0.61-1.04],0.0886836221397168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,15563,139,0.85 [0.57-1.28],0.432836544480054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,18216,160,0.99 [0.63-1.57],0.9670478017191356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,16064,141,0.93 [0.77-1.13],0.4635997088803474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,15598,136,0.95 [0.77-1.16],0.5996256669630664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELN,Elastin,16089,144,1.33 [0.83-2.13],0.232719363787355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,18440,167,1.21 [0.99-1.49],0.0672802745989389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,15563,139,0.77 [0.48-1.24],0.2829260405381807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,18216,160,0.91 [0.67-1.23],0.5481938509518188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,14845,134,0.96 [0.71-1.29],0.7715157800558969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,18759,168,1.71 [0.79-3.72],0.1747761336113928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,18517,170,0.96 [0.81-1.14],0.6189811032719152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,18697,171,0.89 [0.72-1.09],0.2617830462572134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,15641,140,0.72 [0.54-0.97],0.0313733177056152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,16032,144,0.94 [0.69-1.29],0.7009120446235619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,15563,139,0.84 [0.45-1.54],0.5685497432022406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,15563,139,0.74 [0.46-1.19],0.2152139580245004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,18759,168,2.81 [1.66-4.74],0.0001170574460999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,18589,167,0.86 [0.65-1.14],0.2843629091783186
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,15641,140,0.82 [0.52-1.30],0.4084079156591274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,17944,162,0.99 [0.83-1.17],0.8688112207817222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,16032,144,1.04 [0.77-1.40],0.8062045206879782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,18107,161,0.92 [0.67-1.28],0.6270754085610133
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,18197,158,0.82 [0.43-1.55],0.5350777711853634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,18197,158,0.89 [0.54-1.46],0.6479355858643754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,15641,140,1.02 [0.79-1.34],0.8582516859936702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,15604,137,0.90 [0.52-1.56],0.710017071896196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,15673,134,0.90 [0.68-1.20],0.463962843181497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,18493,166,1.04 [0.90-1.20],0.574840988316847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,16032,144,0.99 [0.70-1.41],0.9604461773681876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,18555,167,1.05 [0.68-1.62],0.8295928520927771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,18133,164,1.07 [0.88-1.31],0.4732101752101263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,17885,164,1.95 [1.30-2.93],0.0011440420366215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,15738,143,1.82 [1.05-3.16],0.0331715977237712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,18759,168,1.62 [0.96-2.74],0.0701511783060641
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,18351,166,2.47 [1.65-3.69],1.12748225167278e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,18197,158,1.00 [0.80-1.27],0.9740344923482076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,15807,138,0.96 [0.66-1.42],0.8569325339361694
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,18524,168,1.38 [1.19-1.60],1.8955500497840205e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,15641,140,0.99 [0.79-1.25],0.960670994682424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,18673,165,1.31 [0.84-2.06],0.2392294352693917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,18574,169,0.47 [0.29-0.76],0.002000356235398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,18435,165,0.54 [0.26-1.11],0.0941787447230892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,18574,169,0.62 [0.36-1.07],0.0876497399027411
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,18440,167,0.96 [0.84-1.09],0.5166899697974745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,15673,134,1.03 [0.83-1.28],0.7856808322233718
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,15529,136,1.01 [0.63-1.63],0.9611209513420522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,18351,166,0.95 [0.80-1.13],0.5496580299738667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,15807,138,1.43 [0.93-2.18],0.1009436967324815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,15604,137,0.84 [0.58-1.23],0.376080687575981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,16032,144,0.92 [0.59-1.43],0.713425406517777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,15738,143,0.92 [0.80-1.05],0.2029859985080735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,18414,167,0.55 [0.32-0.94],0.0294703793912636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,15563,139,0.85 [0.57-1.28],0.4484807381851696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,18759,168,0.81 [0.52-1.24],0.3251422091603226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,18498,166,1.31 [0.88-1.95],0.1818960339938505
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,15529,136,1.16 [0.91-1.49],0.238761253152755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,15604,137,1.08 [0.82-1.42],0.5890001409980663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,16058,142,0.92 [0.76-1.12],0.4208587374123486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,15529,136,0.99 [0.65-1.51],0.9704761780790472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,15604,137,0.87 [0.73-1.05],0.1574943254345681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,15807,138,0.85 [0.50-1.44],0.5385977436369868
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,15563,139,1.00 [0.75-1.34],0.9781926248652856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,15563,139,0.84 [0.57-1.23],0.3639952824053752
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,18697,171,2.88 [1.81-4.57],7.692649272843407e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,16110,145,0.89 [0.51-1.54],0.6685068635073574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,15884,140,0.74 [0.42-1.32],0.3109373444969651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,18530,168,0.92 [0.72-1.18],0.5002804536443589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,16113,144,0.93 [0.63-1.37],0.7070679329577867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,16042,141,1.43 [0.76-2.70],0.2660726504197642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,16113,144,1.16 [0.40-3.32],0.7852600684482504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,18567,166,1.02 [0.80-1.30],0.8692729949388682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,18581,165,0.88 [0.51-1.51],0.6475087595192303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,18587,165,0.88 [0.57-1.36],0.5573699706151867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,18594,165,0.82 [0.39-1.74],0.6060235013689117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",18498,166,1.11 [0.96-1.28],0.1569705304933083
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",18528,166,1.12 [0.95-1.33],0.1680449680199107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",16089,144,1.27 [0.96-1.67],0.093856259445393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",18759,168,1.20 [0.91-1.57],0.1878394298303867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,18636,170,1.00 [0.81-1.22],0.9672942882505238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,18167,158,0.95 [0.74-1.22],0.6843970522213043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,18524,168,0.97 [0.76-1.23],0.7853409353885861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,18528,166,0.87 [0.72-1.04],0.1264501344947577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,16036,144,0.88 [0.69-1.12],0.2829030576874145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,16064,141,0.93 [0.83-1.04],0.2052471168655464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,16032,144,0.93 [0.51-1.70],0.8080219892574391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,15641,140,0.96 [0.73-1.25],0.7537605959223577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,16089,144,1.18 [0.67-2.07],0.5709335844264012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,18440,167,1.16 [0.78-1.72],0.4749608982242774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,18507,165,1.41 [0.90-2.23],0.1360018208332858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,16036,144,1.10 [0.92-1.32],0.3092705946976902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,18759,168,0.64 [0.39-1.05],0.0757051342769745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,15673,134,0.93 [0.73-1.19],0.580410745829151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,18698,167,1.29 [0.93-1.79],0.1244132536779455
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,18751,169,1.43 [0.99-2.08],0.0562537569952158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,16098,144,1.78 [1.07-2.95],0.0250788879571298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,15673,134,1.31 [1.00-1.71],0.0515130656787946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",18528,166,0.92 [0.76-1.11],0.3648563281608089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,16089,144,2.05 [1.67-2.51],3.2138772635144187e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,18524,168,1.08 [0.82-1.44],0.5773270461109075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,16064,141,1.13 [0.58-2.22],0.7207945496611238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,18530,168,2.19 [1.81-2.65],7.375527247985645e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,18468,162,1.21 [0.93-1.57],0.1569026929658277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,18107,161,1.20 [0.95-1.50],0.1296085714001227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,18560,165,1.33 [0.99-1.78],0.0567880187275051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,16088,144,1.29 [0.94-1.76],0.1104271534090857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,18467,164,1.20 [0.84-1.71],0.3249431075600196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,18528,166,2.76 [2.21-3.45],2.9930882428140603e-19
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,18665,167,2.92 [2.51-3.41],2.461537050218645e-43
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,18216,160,2.38 [1.92-2.93],8.895814049464475e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,18530,168,1.67 [1.32-2.10],1.3571447999262996e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,18524,168,1.37 [1.12-1.68],0.0021577749243975
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,18107,161,1.43 [1.22-1.68],9.80841646274474e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",15563,139,1.14 [0.91-1.44],0.2609606650582619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",15563,139,0.90 [0.66-1.22],0.4851929918578448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,18107,161,1.06 [0.87-1.29],0.5496200983637656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,18107,161,0.81 [0.59-1.11],0.1869280252879465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,18594,165,1.10 [0.71-1.70],0.6765756432710859
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,15745,140,1.67 [0.99-2.80],0.0524828339775393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",16064,141,0.94 [0.77-1.15],0.5539582575237421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,15604,137,1.06 [0.77-1.46],0.7143709222987388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,15604,137,0.89 [0.60-1.30],0.5308278155865706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,18589,167,0.94 [0.79-1.12],0.5117200082124089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,18524,168,0.99 [0.81-1.21],0.9115997618450612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,15604,137,0.98 [0.67-1.44],0.9138697370578756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,18678,165,0.97 [0.86-1.09],0.5814816874547715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,18671,165,1.10 [0.84-1.42],0.4885258535769126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,15604,137,0.93 [0.53-1.64],0.8095361784602164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,18216,160,1.00 [0.66-1.53],0.9885813698268404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,15604,137,0.99 [0.65-1.51],0.9736867091835146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,15529,136,0.90 [0.71-1.14],0.4010539317546483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,15502,136,0.88 [0.58-1.32],0.5261562777611486
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,18574,169,0.61 [0.41-0.90],0.0130053176203234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,16098,144,0.79 [0.57-1.08],0.1371291695618383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,16058,142,0.88 [0.57-1.36],0.5704067328701966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,18574,169,0.79 [0.42-1.47],0.4535769025933208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,15738,143,1.04 [0.76-1.42],0.7940003563704673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,16110,145,1.22 [0.95-1.56],0.1160232610658738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,18133,164,1.10 [0.89-1.35],0.3899735972187108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",15598,136,1.13 [0.96-1.34],0.1518739368575969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,15563,139,1.21 [0.89-1.63],0.2209576901962229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,18133,164,0.87 [0.72-1.06],0.1673699213959669
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,18496,166,0.93 [0.77-1.11],0.419694374910584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,16064,141,0.88 [0.75-1.04],0.131943200146252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,18600,169,0.93 [0.82-1.05],0.2235855227501441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,18379,166,1.00 [0.72-1.39],0.9920342477033948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,18379,166,0.99 [0.86-1.15],0.916282236305821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,18105,164,1.01 [0.75-1.36],0.9356021161811664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,16036,144,0.86 [0.66-1.13],0.2836011821461633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,18107,161,0.98 [0.86-1.11],0.7585811766690861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,18379,166,1.68 [1.06-2.68],0.0285072635208341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,18403,167,0.55 [0.28-1.08],0.0807581839279494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,18107,161,1.22 [0.78-1.90],0.3814573128622837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,18751,169,1.19 [0.80-1.76],0.3852453930949208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,18574,169,0.93 [0.63-1.38],0.7242445556748243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,18133,164,1.08 [0.89-1.31],0.4505895439667382
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,18107,161,0.85 [0.57-1.27],0.4209384163068921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,16113,144,0.62 [0.34-1.13],0.1214580862056947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,16058,142,0.64 [0.46-0.90],0.0099990945928498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,16032,144,1.09 [0.70-1.70],0.6995254763761387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,15604,137,1.01 [0.86-1.18],0.9108812172297936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,18492,169,1.22 [0.77-1.95],0.399557718913436
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,18697,171,1.63 [1.03-2.57],0.0372803537737681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,18518,169,1.04 [0.97-1.11],0.298303570185928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,15502,136,0.85 [0.53-1.36],0.4959673754937087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,18133,164,1.17 [0.85-1.62],0.3248454053036462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,15604,137,0.84 [0.57-1.25],0.3915379463325432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,18524,168,1.04 [0.89-1.22],0.5998139884921048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,18107,161,1.01 [0.87-1.17],0.9282570810111356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,15563,139,0.83 [0.65-1.07],0.1506858663704955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,15673,134,1.11 [0.69-1.79],0.6740341827471781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,18322,165,1.24 [0.70-2.20],0.4581619884659484
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,15641,140,1.49 [1.14-1.96],0.0038736416626254
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FST,Follistatin,18567,166,1.13 [0.85-1.50],0.3894425967554387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,15641,140,1.99 [0.99-4.03],0.0544416273553963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,18468,166,1.85 [1.23-2.76],0.002871565514704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,16020,142,0.94 [0.77-1.14],0.5144972843517688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,18625,163,1.01 [0.86-1.20],0.868932049273607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,15738,143,0.98 [0.76-1.27],0.8978917241825122
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FURIN,Furin,18574,169,0.51 [0.34-0.77],0.0013184343567408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,18077,161,1.26 [0.90-1.76],0.1825368743990383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",15780,138,1.06 [0.82-1.37],0.6611840965405287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,18697,171,1.33 [1.00-1.77],0.0534541823976691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",18379,166,1.05 [0.83-1.32],0.7033997499568472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",18701,165,0.91 [0.75-1.10],0.3417867948113978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,18216,160,0.89 [0.71-1.12],0.3271138379253301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,18492,168,0.92 [0.80-1.07],0.2783376764563192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,15673,134,1.14 [0.90-1.44],0.2848263567915089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,15598,136,0.97 [0.66-1.43],0.8891094441865898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,16032,144,1.28 [0.96-1.72],0.0898823188400151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,15807,138,0.87 [0.65-1.14],0.3079774089401339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,15598,136,1.04 [0.81-1.34],0.7577875348650189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,15529,136,0.86 [0.46-1.62],0.6378483014825519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,15604,137,1.00 [0.70-1.43],0.9929585257375704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,15807,138,1.22 [0.95-1.58],0.1243071775891799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,15641,140,0.94 [0.69-1.29],0.705872728559146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,15529,136,1.11 [0.88-1.38],0.3800720856783054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,18589,167,0.83 [0.68-1.03],0.0888769901381381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,18440,167,1.68 [1.03-2.74],0.0360092057374377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,18701,165,0.93 [0.56-1.56],0.7947693302887475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,18216,160,1.76 [1.32-2.34],0.0001230437174026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,16089,144,1.31 [0.77-2.23],0.3212094848275427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,18440,167,1.02 [0.53-1.99],0.943297521890021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,15563,139,0.94 [0.58-1.55],0.8229171181750261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,15392,139,0.95 [0.56-1.61],0.8556031967077884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,16064,141,0.61 [0.30-1.24],0.1692780572637265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,15807,138,0.75 [0.51-1.09],0.1302386680849586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,18639,167,0.79 [0.46-1.38],0.4141814595046453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,15563,139,0.70 [0.48-1.02],0.0656848536445805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,16058,142,1.09 [0.98-1.22],0.1050033043515884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,15529,136,0.84 [0.45-1.58],0.588738254022427
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",15641,140,0.95 [0.76-1.18],0.6355286675568804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,15673,134,0.91 [0.67-1.24],0.5561669992401768
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,16030,142,1.63 [1.32-2.02],7.795605295823723e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,18216,160,1.25 [1.01-1.55],0.0363854170272175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,18133,164,1.00 [0.75-1.33],0.9921900531941432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,15563,139,1.18 [0.86-1.62],0.3061936541976899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,16113,144,1.47 [0.81-2.70],0.2080438154566783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,16058,142,0.94 [0.81-1.08],0.3789639337275212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,18107,161,0.95 [0.85-1.06],0.3567834538508341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,15358,137,1.40 [1.06-1.84],0.0168648108092477
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,15563,139,0.77 [0.51-1.16],0.2106383852487751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",18440,167,2.91 [2.03-4.18],6.031264746480841e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,18759,168,1.56 [1.20-2.04],0.0009314217743958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,18528,166,0.62 [0.42-0.91],0.0154857666989599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,18133,164,1.23 [0.86-1.75],0.252071640148002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,16089,144,0.95 [0.69-1.30],0.7422845462882139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,18076,160,0.88 [0.64-1.19],0.39822200261084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,18107,161,1.08 [0.86-1.34],0.5083345874121306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,18107,161,0.99 [0.89-1.12],0.9313288389386276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,18678,165,1.68 [1.05-2.69],0.0313451571887848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,18440,167,1.20 [0.62-2.34],0.5881133616522659
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,18321,164,0.96 [0.58-1.59],0.8866761822931912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,15595,139,1.15 [0.89-1.48],0.295927398106263
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,18133,164,0.83 [0.66-1.06],0.1353204394721877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,16089,144,0.87 [0.69-1.10],0.2490004733932339
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,16062,144,0.96 [0.68-1.34],0.8043141158030989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,18229,159,1.16 [0.77-1.75],0.4783196932995165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,18498,167,0.91 [0.69-1.21],0.5275692317373823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,18379,166,1.44 [0.82-2.54],0.2088187005317073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,18507,165,1.04 [0.97-1.13],0.2588463736598089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,18107,161,0.97 [0.88-1.06],0.4965620945835132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,15738,143,0.48 [0.27-0.85],0.012214675684701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,18133,164,0.73 [0.53-1.00],0.0534822106995004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,18528,166,1.07 [0.91-1.27],0.3944495443140501
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,16064,141,0.97 [0.59-1.58],0.8991343742147656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,16064,141,1.04 [0.84-1.28],0.7264118455497093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,15738,143,1.72 [1.19-2.48],0.0038476712025894
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,15529,136,1.22 [0.91-1.65],0.1830075060276988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,15641,140,1.13 [0.84-1.52],0.4049880435157366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,16058,142,2.22 [1.45-3.41],0.0002394410114777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,16036,144,0.89 [0.76-1.05],0.1679220402201009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,15604,137,0.62 [0.40-0.97],0.035579168845397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,15604,137,0.91 [0.77-1.08],0.2874973706488056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,15529,136,1.17 [0.94-1.45],0.1580933090427956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,17790,162,1.15 [0.69-1.89],0.5938836080327343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,15710,142,0.99 [0.64-1.51],0.9560584070001584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,18379,166,1.10 [0.80-1.52],0.5413773396719572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,15604,137,1.18 [0.75-1.88],0.4739976924451066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,18197,158,0.98 [0.77-1.26],0.9027122285449152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,18474,165,0.98 [0.66-1.47],0.9291954090189912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,15598,136,0.68 [0.41-1.15],0.1493835017003381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,18408,166,0.99 [0.77-1.26],0.9088841928033532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",15738,143,0.88 [0.73-1.06],0.16815344098418
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,18133,164,1.00 [0.74-1.36],0.9872580343232442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,16032,144,1.09 [0.84-1.41],0.5120968029570068
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,15704,136,1.36 [0.92-2.01],0.1261207874368463
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,16089,144,0.93 [0.74-1.16],0.5083029102778911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,18751,169,0.82 [0.62-1.07],0.140044480547612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,15738,143,0.82 [0.64-1.05],0.1181717337463931
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,16064,141,0.81 [0.65-1.01],0.0596443368128326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,18107,161,0.84 [0.67-1.04],0.1130189139227776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,15673,134,0.77 [0.52-1.14],0.1871595279912598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,18530,168,1.27 [0.99-1.63],0.0583764401780835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,15641,140,1.28 [0.90-1.82],0.1639713095486313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,15738,143,0.68 [0.43-1.07],0.0985460045578725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,16064,141,0.94 [0.76-1.16],0.5358780685513225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,18697,171,1.82 [1.17-2.83],0.0079756230273555
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,18524,168,0.96 [0.84-1.09],0.5169684274116078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,16036,144,0.80 [0.57-1.14],0.2131160046858777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",16098,144,1.09 [0.75-1.58],0.637745123808772
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,18475,164,0.84 [0.55-1.28],0.4239985684816861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,15563,139,0.87 [0.69-1.11],0.2622387847466595
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,17960,152,0.97 [0.81-1.15],0.6994888076624587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,15738,143,0.78 [0.51-1.20],0.2612145542846791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,18492,168,0.94 [0.81-1.10],0.4372289046638093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,18440,167,1.07 [0.96-1.18],0.2164577599465577
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,18701,165,0.51 [0.32-0.82],0.0054803373338128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,18379,166,0.83 [0.65-1.06],0.130467834601952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,16032,144,0.83 [0.61-1.14],0.2557179393294654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,16036,144,1.27 [0.94-1.72],0.1232787320264802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,16110,145,0.99 [0.71-1.39],0.9544997165309834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,16036,144,1.03 [0.83-1.29],0.7727431469923156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,18133,164,1.16 [0.76-1.76],0.4907138772618123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,18039,164,1.36 [0.84-2.21],0.2113718508758929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,15598,136,0.73 [0.51-1.07],0.1047304016061545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,16064,141,0.75 [0.44-1.27],0.2836351149907317
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,16036,144,1.23 [0.95-1.58],0.113937004733222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,18197,158,1.12 [0.89-1.39],0.3315202177201525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,16032,144,1.02 [0.77-1.36],0.8951837278401128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,18528,166,0.94 [0.84-1.04],0.2365548554659738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,16089,144,0.93 [0.72-1.20],0.5799374999948211
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",16064,141,0.60 [0.38-0.94],0.0270954896582337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",15598,136,0.77 [0.53-1.12],0.1762569471458923
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,18197,158,0.96 [0.72-1.28],0.7820394663699259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,18430,167,2.81 [1.69-4.67],7.226183805546085e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,15641,140,0.89 [0.66-1.21],0.461501011141483
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",18440,167,1.28 [1.04-1.58],0.022561191690785
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,15442,136,0.93 [0.75-1.14],0.4717567723108212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,18107,161,1.01 [0.85-1.19],0.9470924430164456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,16042,145,0.53 [0.23-1.21],0.1323179687586837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",16025,144,1.60 [0.79-3.23],0.1905233521610061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,18499,166,0.91 [0.77-1.08],0.2636038035695938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,18107,161,0.84 [0.69-1.02],0.0795623183311858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,15563,139,0.93 [0.73-1.18],0.538385353609679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,18020,164,0.93 [0.76-1.15],0.5055508529128206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,16058,142,1.02 [0.96-1.09],0.5026489363650428
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,15807,138,0.87 [0.66-1.15],0.3384853070155954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,15673,134,0.93 [0.75-1.14],0.4661893725429353
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,18428,167,1.31 [0.89-1.95],0.174040716874529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,15807,138,1.04 [0.85-1.26],0.7234929624479222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,15563,139,0.99 [0.65-1.50],0.9678520494955064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,18604,165,0.87 [0.70-1.10],0.2441120169547451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",18197,158,0.90 [0.77-1.05],0.1786943947801546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,18751,169,2.50 [1.81-3.44],2.2932415220369213e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,18524,168,0.85 [0.68-1.06],0.154897903503293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,18197,158,1.24 [1.07-1.42],0.0031571139053906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,15529,136,0.97 [0.69-1.36],0.8662462688205869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",15563,139,0.91 [0.69-1.20],0.497307687909982
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",18652,165,1.00 [0.82-1.22],0.993850572331741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,18701,165,1.00 [0.90-1.12],0.9429104522243608
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",18530,168,0.95 [0.80-1.14],0.5822710884237913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,18675,165,1.20 [0.97-1.49],0.0938484363446356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,18530,168,1.94 [1.36-2.77],0.00023731284584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,18652,165,0.89 [0.74-1.07],0.2179725442560253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,18701,165,1.03 [0.83-1.28],0.7678692123123774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,16089,144,0.97 [0.83-1.13],0.6815445331421948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,15563,139,1.06 [0.81-1.39],0.6509113789301922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,18751,169,0.99 [0.77-1.26],0.9243466451983292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,15604,137,1.01 [0.77-1.33],0.9482303211582738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,15598,136,0.80 [0.59-1.09],0.1627154640334706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,16036,144,0.92 [0.63-1.32],0.6443691052886313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,18666,165,1.10 [0.95-1.27],0.2235494941317202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,16058,142,1.16 [0.91-1.47],0.2249799077331645
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,18197,158,0.87 [0.66-1.16],0.3540435640457274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,15738,143,1.35 [0.74-2.44],0.3240946427791778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,16058,142,0.94 [0.65-1.36],0.7529450206616297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,16089,144,1.29 [0.71-2.36],0.4057345448426986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,18524,168,0.93 [0.78-1.10],0.3920229207525872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,18751,169,1.17 [0.79-1.72],0.4392073091550925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,15967,142,0.51 [0.30-0.88],0.0150118712215531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,18107,161,0.89 [0.74-1.08],0.2372043337280496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,16058,142,0.95 [0.77-1.17],0.6311808738639568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,15604,137,1.19 [0.96-1.48],0.1119646118468034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,15563,139,1.03 [0.64-1.65],0.9004417313759929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,16021,140,1.41 [1.11-1.77],0.004342432002199
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,16064,141,1.09 [0.76-1.57],0.6430130178632575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,18197,158,1.15 [0.69-1.93],0.5826070758534974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",16064,141,1.38 [0.84-2.25],0.2047292695485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",18462,168,1.38 [0.96-1.98],0.0856662608347197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",18524,168,2.22 [1.49-3.30],8.289745891837417e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,18701,165,0.95 [0.68-1.33],0.7762876488343273
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,15708,143,1.07 [0.81-1.42],0.6196879628806462
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",15641,140,0.84 [0.60-1.19],0.3351489434696089
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",15563,139,0.98 [0.67-1.43],0.9067973579553672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,15491,136,0.96 [0.67-1.37],0.8309157477683632
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,18329,164,1.36 [1.04-1.78],0.0262528904436905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,18133,164,1.39 [1.09-1.76],0.006841203317682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,15673,134,1.07 [0.86-1.32],0.5566304064148164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,18294,165,1.45 [1.09-1.93],0.0103023786452574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,18128,154,0.97 [0.80-1.16],0.7140160188322799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,16064,141,1.13 [0.84-1.53],0.4209470831370103
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,18751,169,0.98 [0.81-1.17],0.7950313601290268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,18107,161,0.67 [0.45-0.98],0.038701283897051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,15900,140,0.93 [0.79-1.11],0.4313711685919936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,15778,138,0.95 [0.79-1.14],0.6044908755430235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,15641,140,1.38 [0.87-2.19],0.1722375675635913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,16042,141,0.98 [0.59-1.63],0.9436726720427554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,15641,140,0.96 [0.80-1.16],0.701521807048474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,18440,167,1.26 [0.88-1.82],0.2123667832378834
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,18701,165,1.57 [1.19-2.08],0.0014407188498684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,15604,137,0.92 [0.59-1.44],0.7188307201734037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,15641,140,1.12 [0.94-1.32],0.1991973317217774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,18524,168,1.07 [0.76-1.50],0.7114419687871565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,16058,142,1.06 [0.82-1.37],0.6713570855820172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,15563,139,1.18 [0.87-1.59],0.2939614276383757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,15641,140,1.10 [0.79-1.54],0.5627620101473889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,18049,163,0.99 [0.79-1.23],0.9002971177886071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,18555,167,0.95 [0.78-1.16],0.641267221533062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,16032,144,1.13 [0.73-1.75],0.5877992670077798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,18238,165,0.83 [0.69-1.00],0.0459797589534742
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,18701,165,1.49 [1.08-2.04],0.015350887193743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,18412,161,1.34 [0.80-2.25],0.2616172342658265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,15598,136,1.03 [0.82-1.29],0.8215010704252839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,15598,136,0.80 [0.53-1.22],0.3006950825749478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",18574,169,0.97 [0.77-1.21],0.7737375255883459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,18455,166,0.63 [0.34-1.16],0.137951022729591
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,18759,168,1.52 [0.84-2.74],0.1646342923330337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,18216,160,0.92 [0.77-1.10],0.3544066248044045
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,18469,163,2.41 [1.54-3.76],0.0001114137587587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,18759,168,1.59 [1.04-2.43],0.0312696704765957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,18759,168,6.01 [4.04-8.95],1.1035349965158132e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,18524,168,0.80 [0.62-1.03],0.0793904265752761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,18528,166,1.03 [0.77-1.39],0.8365782109628682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,18440,167,1.05 [0.51-2.17],0.890188521413518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,15807,138,0.89 [0.59-1.34],0.5675744672557499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,18133,164,1.04 [0.79-1.38],0.7655092792407512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",15641,140,1.36 [1.08-1.72],0.0098842717235417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,18751,169,1.34 [0.29-6.20],0.7075117421816581
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,18701,165,0.96 [0.72-1.29],0.8005587314760081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,15666,136,2.64 [1.87-3.71],2.653291530615654e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,15807,138,0.99 [0.72-1.36],0.9529329026674256
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,15807,138,0.82 [0.52-1.29],0.3851589581056264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,16036,144,1.79 [1.05-3.02],0.0308254554575213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,18216,160,1.15 [1.01-1.30],0.0297979193996854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,18589,167,2.26 [1.36-3.76],0.0016426096082807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,18379,166,0.87 [0.66-1.14],0.2976090496418512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,18133,164,1.62 [1.25-2.10],0.0002972591035946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,15598,136,1.06 [0.82-1.37],0.6546085005690963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,18524,168,1.90 [1.49-2.44],3.525149590311647e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,15563,139,0.77 [0.45-1.32],0.3485118785698203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,15673,134,0.75 [0.50-1.13],0.1653646093129613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,16064,141,0.84 [0.64-1.10],0.1947882212556682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,15598,136,0.82 [0.54-1.22],0.3264342934624941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,16098,144,0.59 [0.34-1.01],0.0524576149394324
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,18440,167,1.01 [0.53-1.92],0.968345754571651
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,15563,139,0.91 [0.62-1.33],0.6294032055281924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,18530,168,1.11 [0.62-1.96],0.728322917410088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,18734,168,1.10 [0.98-1.22],0.100307616932359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,18729,168,1.50 [1.20-1.89],0.0004665904219099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,18617,166,0.90 [0.59-1.36],0.6140053276969663
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,18306,167,1.44 [1.08-1.91],0.0124924996344197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,18465,162,1.14 [0.73-1.79],0.5539932961568567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,18759,168,1.45 [0.98-2.13],0.0612572871291593
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,18528,166,1.24 [0.83-1.85],0.3016471773071554
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,15604,137,1.12 [0.92-1.36],0.2631466925200743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,15563,139,0.81 [0.59-1.12],0.1996743597146739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,16091,144,1.45 [0.95-2.24],0.0883647984020799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,15529,136,1.00 [0.84-1.20],0.960078922163237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,15641,140,0.68 [0.43-1.07],0.0937251885365174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,18440,167,1.70 [1.18-2.43],0.0039434072820656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,18528,166,1.17 [0.75-1.82],0.4790843712443519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,16089,144,0.81 [0.67-0.98],0.0304660169490384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,18524,168,0.97 [0.83-1.13],0.6834508827354326
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,18107,161,1.11 [0.96-1.27],0.1521434126738472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,18216,160,1.44 [1.27-1.62],8.345229741168562e-09
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,18216,160,1.22 [1.00-1.48],0.0453008627150979
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,18589,167,1.76 [1.20-2.58],0.0036297668337207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,18216,160,0.91 [0.72-1.16],0.4586888506696708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,18440,167,1.97 [1.69-2.30],2.7452244562872052e-18
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,18751,169,2.68 [2.12-3.38],1.3631132992441798e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,18216,160,2.30 [1.67-3.16],3.170225859945955e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,15604,137,1.18 [0.80-1.73],0.3974025708786041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,18216,160,1.16 [0.92-1.45],0.2064251148718146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,18288,167,0.63 [0.37-1.07],0.0882632785304723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,15598,136,0.81 [0.47-1.42],0.4722774872027405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,18524,168,0.96 [0.63-1.46],0.8426244453682437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,18216,160,2.29 [1.55-3.38],3.096336957448554e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,18751,169,1.51 [1.16-1.97],0.0019854491576442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,18176,160,1.00 [0.72-1.39],0.988970917567753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,18216,160,1.11 [0.92-1.34],0.265549597433098
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,18216,160,0.98 [0.65-1.48],0.9315331943224464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,18216,160,1.10 [0.92-1.30],0.3015104249574533
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,18530,168,0.97 [0.71-1.31],0.826647829846938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,18301,168,1.20 [0.93-1.54],0.1648204284593093
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,18434,165,1.75 [1.32-2.32],0.0001006480991943
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,18617,166,2.74 [1.86-4.03],3.59654211837712e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,18751,169,1.68 [1.12-2.51],0.0120520291658452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,18265,165,1.03 [0.95-1.11],0.5432104592603553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,18066,165,1.15 [0.96-1.37],0.1404834818668836
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,18216,160,1.02 [0.81-1.28],0.8499486031032295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,18130,159,1.01 [0.79-1.29],0.9233259572314796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,18498,167,2.04 [1.18-3.51],0.0106955051857195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,18468,165,0.70 [0.35-1.39],0.3129709052592941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,18530,168,1.06 [0.79-1.42],0.7110944689753362
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,18698,167,1.29 [0.96-1.74],0.0905661266794451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,18216,160,1.15 [0.79-1.68],0.4731893683315173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,18467,166,1.26 [0.99-1.59],0.0566805998049009
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,18216,160,1.49 [0.96-2.29],0.073459426253452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,18216,160,1.09 [0.84-1.43],0.5206394508232115
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,18216,160,1.23 [0.96-1.59],0.1029877644109129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,15604,137,1.09 [0.74-1.61],0.6584508008788561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,15604,137,1.01 [0.76-1.35],0.9494064037745976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,16032,144,1.06 [0.84-1.33],0.6365422543172146
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,18216,160,1.17 [0.89-1.53],0.2619868293782557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,18216,160,0.91 [0.67-1.23],0.5275208250035848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,15471,136,0.83 [0.52-1.35],0.4621914894217838
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,18411,165,3.34 [2.68-4.17],1.440439077737359e-26
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,18216,160,1.39 [1.01-1.90],0.0417622488192656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,16032,144,1.52 [1.10-2.10],0.0121039593541965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,15529,136,1.03 [0.78-1.34],0.8549622275336812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,15604,137,0.73 [0.51-1.06],0.0991580094767513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,15548,137,1.04 [0.67-1.62],0.8557188903363587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,18524,168,1.61 [1.23-2.10],0.000463505989735
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,18216,160,1.36 [0.96-1.93],0.0824517497803733
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,18103,164,1.38 [0.93-2.05],0.1130126007318753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,15604,137,0.95 [0.70-1.28],0.7374088994705701
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,15558,136,0.95 [0.73-1.23],0.6853430295182081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,18216,160,1.22 [0.79-1.89],0.3741878926040276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,18216,160,0.98 [0.85-1.14],0.8227823885945229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,18524,168,1.66 [1.16-2.36],0.0053028506009902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,18216,160,0.99 [0.89-1.10],0.8288492134991745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,18524,168,1.11 [0.87-1.41],0.4113967218340749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,18440,167,1.30 [1.13-1.50],0.0002416814134405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,18444,163,1.11 [0.74-1.66],0.6082952728156761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,18528,166,1.29 [0.59-2.83],0.5235285667818796
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,18524,168,0.85 [0.69-1.06],0.1483252150750283
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,18530,168,1.09 [0.84-1.42],0.5180064802933143
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,15807,138,0.97 [0.71-1.32],0.8548194324638709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,18100,162,1.01 [0.80-1.29],0.9054616021168778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,16032,144,1.28 [0.93-1.75],0.1296762916381747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,18379,166,1.01 [0.80-1.27],0.9367962948857028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,16058,142,0.85 [0.64-1.15],0.2938798645969227
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,15598,136,0.59 [0.31-1.10],0.0968220414707666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,18105,164,1.08 [0.82-1.43],0.5874117321959682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,15738,143,1.30 [0.96-1.76],0.089922146303652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,18530,168,0.78 [0.56-1.10],0.1612671135300453
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,18440,167,1.06 [0.82-1.36],0.6713024069622617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",15641,140,1.06 [0.80-1.41],0.6837708371732885
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",16064,141,0.94 [0.62-1.41],0.7502240112067764
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",18440,167,0.95 [0.83-1.10],0.5116819157634094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,16058,142,0.83 [0.70-0.99],0.0375209852031603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,16032,144,0.74 [0.50-1.10],0.1402082769810248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,16036,144,1.01 [0.87-1.19],0.8583215737612142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,15604,137,1.55 [0.58-4.10],0.3819483762638986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,18344,165,0.98 [0.84-1.14],0.7654787499437069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,18440,167,0.99 [0.77-1.28],0.946309193049667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",18197,158,1.09 [0.94-1.27],0.2528327786915383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,18216,160,0.95 [0.78-1.17],0.6600643154408101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,18524,168,0.94 [0.83-1.07],0.3549696151534232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,17858,163,0.62 [0.43-0.89],0.0092683151488152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,18524,168,0.74 [0.52-1.05],0.0867711214031922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,16098,144,0.84 [0.57-1.24],0.3811705701934532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,15910,144,0.89 [0.76-1.05],0.1764665248137854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,18524,168,0.55 [0.37-0.83],0.003861207602399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,15738,143,0.75 [0.47-1.20],0.2334938247644519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,18530,168,1.43 [0.82-2.47],0.2030494762140598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,18524,168,0.73 [0.55-0.97],0.0308389903111242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,15604,137,1.85 [1.24-2.76],0.002621473528538
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,18530,168,0.94 [0.61-1.45],0.7719861504680476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,18701,165,0.44 [0.20-0.99],0.0476643969424945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,15807,138,1.09 [0.81-1.47],0.5761617392455936
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,18531,165,1.00 [0.52-1.94],0.9976453802371472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,18107,161,0.85 [0.60-1.20],0.3581905536376709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,18197,158,1.00 [0.88-1.13],0.9844189576200226
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,18436,163,2.05 [1.34-3.14],0.0009020317779857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,18574,169,0.77 [0.53-1.12],0.169353862662602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,18216,160,0.67 [0.42-1.06],0.0845866173897805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,18701,165,1.43 [1.08-1.89],0.0113410513712002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,16098,144,1.78 [1.23-2.57],0.0021163285519394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,16113,144,1.16 [0.50-2.71],0.731140800766305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,18617,166,1.61 [1.12-2.31],0.0094353428337561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,16113,144,1.29 [0.68-2.45],0.4297189884485946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,16032,144,1.05 [0.74-1.49],0.7730462552413743
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,18524,168,1.28 [1.03-1.59],0.0251214293328798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,15563,139,0.90 [0.70-1.15],0.3990139021758526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",15641,140,1.08 [0.86-1.35],0.5175126187846761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",15598,136,0.79 [0.52-1.20],0.2722156423697087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",18133,164,0.91 [0.69-1.21],0.5145390134906438
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,15529,136,0.82 [0.55-1.23],0.3385802381269369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,18697,171,1.34 [0.81-2.20],0.2529940297754373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,15738,143,0.92 [0.66-1.27],0.5971131099542708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,18216,160,1.29 [1.03-1.62],0.0243706666841212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,15529,136,0.88 [0.64-1.20],0.4098155324788589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,16036,144,0.91 [0.76-1.09],0.3062601613230819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,18216,160,1.31 [1.06-1.63],0.0131652506456027
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,18440,167,1.40 [1.01-1.92],0.0406509335787565
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,16036,144,0.92 [0.79-1.07],0.3017455885222008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,15598,136,0.81 [0.57-1.16],0.257281513495684
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,15673,134,1.12 [0.92-1.36],0.2518909643966994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,18133,164,0.92 [0.69-1.24],0.5958241837854537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,15737,135,1.73 [1.38-2.16],1.6098011692194253e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,15604,137,0.99 [0.82-1.20],0.9103594909191142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,18574,169,0.59 [0.36-0.97],0.0379982651907499
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,18133,164,1.20 [0.82-1.76],0.3531274228160469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,15529,136,1.11 [0.90-1.37],0.3405098275250141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,15641,140,1.00 [0.77-1.30],0.984449459919569
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,16058,142,1.24 [0.76-2.00],0.3872474654182615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,15807,138,0.93 [0.73-1.18],0.545218559128845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,15807,138,0.79 [0.43-1.45],0.440649199522619
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,16032,144,1.05 [0.79-1.39],0.7434348265607963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,15563,139,1.06 [0.67-1.69],0.7938263353349264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,15598,136,1.04 [0.83-1.29],0.7467447605344344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,15563,139,0.95 [0.83-1.08],0.4106496364549614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,18440,167,1.00 [0.85-1.18],0.957135091474282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,16032,144,1.00 [0.83-1.19],0.9638003813991842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,18107,161,1.05 [0.88-1.25],0.599698898338521
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,16036,144,0.98 [0.89-1.08],0.663235799788755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,18107,161,0.85 [0.76-0.96],0.0066864876785149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,15529,136,0.93 [0.74-1.16],0.5040467128319972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,15598,136,0.86 [0.61-1.20],0.3703636455995459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,18133,164,1.22 [0.87-1.69],0.2449804849553549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,18594,165,0.54 [0.34-0.87],0.0104364164170806
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,18528,166,0.86 [0.60-1.24],0.4302822000459175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,18133,164,0.98 [0.82-1.18],0.8480413885244649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,15598,136,0.97 [0.65-1.45],0.8965741925938906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,16064,141,0.92 [0.66-1.29],0.6412748817342551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,18355,166,0.90 [0.81-1.01],0.0716929230281032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,18521,169,0.96 [0.68-1.34],0.792707867695835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,18390,169,1.27 [0.86-1.87],0.234774829914549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,18107,161,1.04 [0.93-1.15],0.491393158779703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,18100,164,1.24 [0.91-1.68],0.1706985084467723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,18701,165,1.01 [0.75-1.35],0.970266509234394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,16001,144,1.14 [0.84-1.56],0.3980802177188195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,16098,144,1.03 [0.89-1.19],0.6548804068644642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,18701,165,1.34 [1.11-1.62],0.0028851205678097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,18537,169,0.98 [0.63-1.52],0.9133528353601336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,15353,138,1.03 [0.67-1.58],0.8869682776255725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,17905,165,1.08 [0.74-1.59],0.6919764202194176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,15793,139,0.74 [0.38-1.44],0.3729303027767623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,18751,169,2.07 [1.49-2.89],1.723604660421665e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,15598,136,1.08 [0.84-1.39],0.5466062008521472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,18751,169,1.76 [1.33-2.34],9.344151116809842e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,15604,137,1.22 [0.91-1.65],0.185978415913863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,16058,142,1.83 [1.44-2.32],8.522573829523155e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",17579,160,1.13 [0.72-1.77],0.5954169629761101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",15563,139,0.98 [0.64-1.49],0.9211926872235818
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",18440,167,1.08 [0.92-1.26],0.3719344723962812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",18493,168,1.08 [0.88-1.32],0.47719063738302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",18133,164,1.15 [0.89-1.49],0.2870525508025898
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",15563,139,1.00 [0.65-1.56],0.9913525216318708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",15598,136,1.03 [0.86-1.25],0.7230940331130545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,18497,166,1.00 [0.78-1.27],0.9755177519812877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,18751,169,1.20 [0.89-1.61],0.2391824159296842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,18574,169,0.99 [0.62-1.57],0.9591914836081664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,16089,144,0.88 [0.74-1.06],0.1706740935238121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,15998,144,0.85 [0.57-1.26],0.4205415632503104
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,18528,166,0.90 [0.73-1.11],0.3271664916315812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,18440,167,1.96 [1.53-2.51],8.237458562925582e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,18498,166,2.09 [1.60-2.74],7.782302589366663e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,18379,166,1.32 [1.15-1.52],0.0001101514685107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,15563,139,0.85 [0.59-1.22],0.3793736250374239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,18589,167,0.67 [0.44-1.01],0.0567822853647203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,15641,140,0.95 [0.56-1.62],0.8611960483591408
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,15662,138,0.66 [0.32-1.35],0.2545247275673922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,17967,160,0.77 [0.40-1.50],0.4454569210229777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,18718,169,1.26 [0.98-1.63],0.0742264788533242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,16032,144,1.28 [0.90-1.84],0.1733135489214706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,18216,160,0.89 [0.66-1.20],0.4473085513478441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,16032,144,0.77 [0.57-1.02],0.0714594241733377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,18751,169,0.92 [0.78-1.10],0.3755683077450445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,18440,167,0.97 [0.87-1.09],0.6404457600455228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,15604,137,0.84 [0.69-1.02],0.0805673518494147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,18351,166,1.71 [1.19-2.46],0.0036365980986036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,18617,166,1.07 [0.85-1.36],0.558494000466925
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,18697,171,1.09 [0.91-1.31],0.3606490938507308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,16110,145,0.84 [0.40-1.74],0.6305222529707342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,16064,141,0.94 [0.71-1.24],0.6593330608497255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,17995,157,1.11 [0.77-1.59],0.5718434261034262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,16098,144,1.35 [0.99-1.83],0.0563864524100653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,18576,167,0.97 [0.74-1.27],0.7984224643503837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,16064,141,0.86 [0.73-1.01],0.0686704572433482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,16089,144,1.05 [0.82-1.34],0.7165659159424879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,18678,165,0.96 [0.74-1.25],0.7620632828416576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,15194,138,1.10 [0.87-1.39],0.435134798487181
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,15598,136,0.99 [0.78-1.25],0.9208541303084034
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,16064,141,1.01 [0.61-1.69],0.9588857982312318
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEP,Leptin,18528,166,0.92 [0.76-1.13],0.4417841705807056
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,18528,166,1.26 [0.83-1.92],0.2775767139857252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,16064,141,1.12 [0.84-1.49],0.4508223032347017
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,18528,166,1.27 [0.87-1.87],0.2203366809516084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,18584,167,1.36 [0.86-2.15],0.1936225272046099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,16113,144,0.80 [0.46-1.37],0.4104658268812482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,18498,166,1.15 [0.91-1.46],0.2479390407833553
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,18498,165,1.35 [1.01-1.82],0.0460180451818172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,18697,171,1.00 [0.80-1.25],0.9771321521506644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,18508,165,3.44 [2.33-5.07],4.2527933647340424e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,18589,167,1.09 [0.75-1.60],0.6436734142410079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,18107,161,0.97 [0.82-1.14],0.6813145545879016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,18526,167,0.96 [0.76-1.20],0.7156653085837935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,18133,164,1.13 [0.89-1.45],0.3196792025653203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,18524,168,1.10 [0.62-1.95],0.7482902258986872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,18530,168,1.81 [1.21-2.71],0.0038247841399546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,16098,144,1.02 [0.91-1.15],0.6864241096348168
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,15563,139,1.06 [0.77-1.46],0.7101770737123954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,18507,165,1.94 [1.28-2.94],0.0016772860463258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,16089,144,1.03 [0.83-1.28],0.7630723328298631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,18759,168,2.51 [1.54-4.11],0.0002293826770917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,18668,167,1.57 [1.04-2.37],0.0315396444820941
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,18216,160,2.13 [1.59-2.86],4.19589484968707e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,18759,168,1.08 [0.89-1.32],0.4222393615571967
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,15641,140,1.15 [0.89-1.49],0.2724604979578542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,16009,144,1.25 [1.01-1.55],0.0398816735773054
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,16058,142,2.95 [2.02-4.32],2.266976641688685e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,16064,141,1.07 [0.67-1.70],0.7868211270983493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,15598,136,1.03 [0.78-1.34],0.8558500749089457
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",15641,140,0.92 [0.76-1.12],0.4148937558553013
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),15757,140,1.02 [0.93-1.12],0.6459462649842096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,18440,167,1.19 [0.92-1.52],0.1798943541506784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,18528,166,0.90 [0.68-1.20],0.4822038592296601
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,17882,160,1.11 [0.88-1.41],0.3578497410602714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,15563,139,0.89 [0.69-1.15],0.3780808495144065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,15563,139,1.07 [0.84-1.35],0.5897573719604021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,15673,134,1.02 [0.71-1.48],0.9145308468040404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,16113,144,2.85 [1.61-5.04],0.0003203905045744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,18652,165,2.19 [1.52-3.16],2.322211467193132e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,15556,137,0.98 [0.53-1.81],0.948335767750306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,18440,167,0.89 [0.53-1.50],0.6740277922363862
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,18528,166,1.15 [0.79-1.67],0.4528022038193854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,15673,134,0.78 [0.47-1.28],0.3269372178163496
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,15673,134,1.03 [0.84-1.27],0.7516501527376819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,18697,171,0.95 [0.74-1.22],0.6908290145976653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,18440,167,1.38 [1.02-1.87],0.0389866079720912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,16036,144,1.39 [0.96-1.99],0.0782607197923756
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,15673,134,0.88 [0.61-1.26],0.4792496146935536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,16089,144,0.94 [0.67-1.32],0.7333275414611058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,16032,144,1.02 [0.73-1.41],0.9247967569677896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,18216,160,0.67 [0.48-0.95],0.025272803368235
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,15673,134,1.43 [1.08-1.88],0.0120639312871514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,16064,141,1.15 [0.62-2.13],0.6574709374285008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,18107,161,1.05 [0.82-1.35],0.7076934024683297
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,15807,138,1.02 [0.84-1.25],0.8215182760198825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,18524,168,1.62 [1.18-2.23],0.0027529429723658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,18524,168,2.40 [1.93-2.98],3.5243964161123235e-15
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,18701,165,1.14 [0.91-1.43],0.2407587675419848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,16032,144,1.28 [0.88-1.87],0.1921326122228662
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,18759,168,2.07 [1.36-3.13],0.0006388111989478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,18107,161,1.13 [0.89-1.45],0.3164528617049909
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,18405,165,2.08 [1.36-3.19],0.0007485848396128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,18216,160,0.98 [0.69-1.39],0.9149988724678024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,16032,144,1.33 [0.97-1.81],0.0760697831272693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LXN,Latexin,18292,162,0.93 [0.76-1.15],0.514615355549932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,18412,166,1.67 [1.22-2.29],0.0013745325161887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,18524,168,1.74 [1.20-2.51],0.0033995382550842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,18300,166,6.36 [4.39-9.22],1.6786108620822801e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,18379,166,1.22 [0.85-1.76],0.2770996830183468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,18107,161,1.22 [1.01-1.48],0.0443059210350286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,18440,167,0.93 [0.80-1.09],0.3913544044223355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,18133,164,0.87 [0.67-1.12],0.2781645422809969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,18434,169,1.07 [0.71-1.60],0.7524542736638191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,18107,161,1.27 [1.02-1.59],0.0306472322162491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,15598,136,0.96 [0.82-1.13],0.6580895132907938
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,15673,134,0.98 [0.83-1.15],0.7694140368316403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,16113,144,1.06 [0.46-2.41],0.8944601124556169
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,15529,136,0.49 [0.29-0.81],0.0061880536760476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,15738,143,0.86 [0.68-1.08],0.1955128362626402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,15641,140,1.27 [0.89-1.81],0.1932307462570036
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,18321,165,1.43 [1.19-1.72],0.0001548465428295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,18107,161,1.06 [0.73-1.52],0.7654718821766349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,15673,134,0.98 [0.69-1.38],0.8998960105774629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,15807,138,0.82 [0.70-0.96],0.0128920524300126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,18107,161,1.29 [0.99-1.69],0.0632171148330232
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,16089,144,1.50 [0.97-2.33],0.0690579801136114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,16032,144,0.82 [0.61-1.09],0.1744212312892075
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",15641,140,3.10 [1.63-5.88],0.0005537874529646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,16089,144,0.93 [0.71-1.21],0.566651315216819
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",15529,136,0.91 [0.65-1.27],0.5793686506159081
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,18589,167,0.98 [0.87-1.09],0.6886706373179927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,18574,169,1.27 [0.78-2.06],0.3436340081810127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,15563,139,1.27 [1.02-1.58],0.0359082893217065
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,15598,136,0.55 [0.33-0.93],0.0243179662917327
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,15563,139,0.98 [0.76-1.27],0.8870541460813026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,16058,142,1.14 [0.82-1.59],0.436031258946753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,16036,144,0.95 [0.74-1.22],0.6967264060780516
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,18524,168,0.90 [0.79-1.03],0.139862985168603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,18107,161,1.01 [0.87-1.17],0.9086157117752246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,18351,166,0.98 [0.86-1.10],0.694806987895815
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,15529,136,1.28 [0.92-1.78],0.1389200812562295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,18524,168,1.02 [0.74-1.40],0.919432485639682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,15807,138,0.99 [0.80-1.24],0.9561107614709904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,15529,136,1.03 [0.93-1.15],0.5324993499291624
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,18133,164,0.96 [0.73-1.24],0.7341854425069039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,18528,166,2.84 [1.66-4.88],0.0001522069635692
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",15710,142,0.92 [0.76-1.12],0.4261694809713422
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,18351,166,0.64 [0.36-1.16],0.1394393273085908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,18528,166,1.41 [0.88-2.26],0.1527691968711459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,18344,165,1.20 [0.80-1.81],0.3749198869761018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,18107,161,1.02 [0.87-1.19],0.7911087175267913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MAX,Protein max,18133,164,1.01 [0.89-1.16],0.8379898061937547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,18759,168,1.15 [0.91-1.46],0.2306093432909178
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,15895,140,1.09 [0.94-1.27],0.2435169367635434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,18617,166,0.90 [0.58-1.38],0.6243556464532416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",16064,141,0.89 [0.59-1.34],0.5796331956142609
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,15604,137,0.95 [0.79-1.15],0.6258758904796766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,18431,166,0.88 [0.64-1.20],0.4134520290827737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,16036,144,0.99 [0.54-1.81],0.976175835191503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,18379,166,1.11 [0.91-1.36],0.3123299710749606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",16027,144,0.96 [0.64-1.45],0.8559303823825782
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDK,Midkine,18511,169,1.07 [0.82-1.39],0.6137796064091328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,15673,134,1.03 [0.60-1.77],0.9209466116259618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",15641,140,0.96 [0.80-1.15],0.6535505144267705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,18107,161,1.01 [0.84-1.22],0.8981689445666514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,15563,139,0.85 [0.58-1.24],0.3950305389587312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,18498,166,0.82 [0.58-1.16],0.2571989891179076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,15563,139,1.20 [0.76-1.87],0.4337251277184722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,18698,167,1.35 [0.67-2.69],0.4005273967305844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,16089,144,0.90 [0.53-1.53],0.7004153417234833
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,15738,143,0.75 [0.38-1.48],0.4074488409283954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,16036,144,0.92 [0.74-1.14],0.4316089986689174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,18528,166,1.01 [0.90-1.14],0.8298035334449135
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,18498,166,0.82 [0.47-1.46],0.5071179646192121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,18751,169,1.79 [1.04-3.09],0.036198372363522
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,18530,168,0.96 [0.86-1.07],0.4599531515960827
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,18573,165,0.85 [0.42-1.73],0.6485798127659097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,18133,164,1.31 [0.84-2.03],0.233368436286688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",18524,168,0.93 [0.79-1.10],0.4192723033739637
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,18678,165,0.94 [0.73-1.20],0.6124805266382465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,18197,158,0.78 [0.56-1.09],0.1405190160194052
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,15673,134,1.03 [0.81-1.33],0.795024291589175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,15738,143,1.32 [0.80-2.17],0.2742411095453138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,18759,168,0.93 [0.66-1.31],0.678019334445917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,18530,168,1.11 [0.82-1.50],0.506082176727545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,18567,166,0.91 [0.78-1.06],0.245225959309547
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,18524,168,0.95 [0.85-1.06],0.3384703806110112
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,18574,169,1.46 [1.03-2.06],0.033333840084588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,15673,134,0.96 [0.75-1.24],0.7621864630292368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,18524,168,1.02 [0.93-1.11],0.7414793601137154
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,18494,167,0.99 [0.81-1.22],0.9327916729301488
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,18216,160,1.46 [1.13-1.90],0.004325376429487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,16032,144,0.94 [0.81-1.08],0.3773976348596913
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,16058,142,0.95 [0.80-1.12],0.533074934311309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,18379,166,0.97 [0.84-1.12],0.6953860421950777
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,15604,137,1.29 [0.93-1.79],0.1332972933668167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,15529,136,0.85 [0.65-1.13],0.2602110616722121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,18524,168,1.12 [0.96-1.30],0.1561145159860966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,18440,167,0.94 [0.78-1.12],0.4906821474841299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,17914,163,1.00 [0.85-1.16],0.9758711526306196
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,18473,164,1.01 [0.79-1.28],0.9496326494172822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,18571,165,1.29 [1.01-1.65],0.0380841118960502
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,18133,164,1.24 [0.81-1.92],0.3247535382027622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,16089,144,1.29 [1.02-1.64],0.0354009443954348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,18530,168,0.92 [0.70-1.22],0.5769485380794096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,18173,158,1.27 [0.95-1.70],0.1125734643080534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,18665,169,0.94 [0.78-1.14],0.5422563693313525
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,18509,167,1.00 [0.79-1.25],0.9865388763796192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",15563,139,0.76 [0.53-1.08],0.1199952534588964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,15673,134,0.78 [0.56-1.09],0.1429084500422598
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,15807,138,1.18 [0.86-1.63],0.3109647089001028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,18499,166,1.01 [0.89-1.16],0.8441176394438658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,15738,143,0.95 [0.74-1.21],0.6612712023069864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,18701,165,0.99 [0.66-1.49],0.9599263872383628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,16058,142,1.53 [0.95-2.46],0.081866582380575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,15807,138,0.95 [0.62-1.46],0.8252654425284208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,15529,136,0.86 [0.54-1.37],0.5224071577976187
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,15529,136,0.97 [0.78-1.21],0.7960836790539055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,18197,158,0.91 [0.75-1.10],0.3255215663462997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,18440,167,0.97 [0.83-1.14],0.7497937819966016
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,18567,166,0.99 [0.83-1.18],0.871651347679308
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,18530,168,1.56 [1.22-1.99],0.0003549118298064
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,16005,144,0.88 [0.61-1.27],0.4993827965526173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,16110,145,1.43 [0.82-2.49],0.2095982344834814
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,15673,134,1.08 [0.84-1.39],0.5339014139142575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",15563,139,1.25 [0.88-1.77],0.2105431049648245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",16064,141,0.86 [0.52-1.42],0.55389334052848
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",18133,164,0.88 [0.53-1.48],0.6299394281769095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",15491,136,1.31 [0.83-2.06],0.2534897461620475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",16064,141,0.94 [0.74-1.19],0.6117062071838884
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",15604,137,0.80 [0.42-1.50],0.4829564616829981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,18410,167,1.08 [0.86-1.35],0.527234708318839
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,15673,134,1.01 [0.65-1.58],0.948817297835286
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,18510,166,1.00 [0.82-1.22],0.9712537720097456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,18697,171,1.26 [0.94-1.70],0.1244014280866051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,18574,169,0.95 [0.79-1.15],0.6308278235762057
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,15879,141,0.88 [0.73-1.07],0.1977873784780906
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,18197,158,0.81 [0.62-1.06],0.1238777606597472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,15604,137,0.99 [0.83-1.18],0.8853998286124847
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",16058,142,1.01 [0.53-1.92],0.9713271600771094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,15807,138,0.93 [0.80-1.07],0.3030586363562861
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",16036,144,0.87 [0.73-1.05],0.1541141777896176
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,18197,158,1.17 [0.79-1.74],0.433986669164021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,15563,139,0.76 [0.56-1.04],0.0838464141525988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,16036,144,0.96 [0.83-1.10],0.5339750838919959
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,16032,144,0.98 [0.83-1.15],0.7711684194780383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,15807,138,0.99 [0.73-1.33],0.9245621303165537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,18133,164,0.98 [0.75-1.29],0.912310881063258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,18440,167,1.03 [0.95-1.11],0.4610553788041448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,16098,144,0.82 [0.69-0.98],0.0312658124896749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,15529,136,0.90 [0.59-1.38],0.6318513558479977
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,18216,160,0.99 [0.83-1.18],0.9140491925449458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,15738,143,1.07 [0.63-1.81],0.8046944478428262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",16089,144,1.15 [0.94-1.40],0.1780328747119537
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",15641,140,0.99 [0.81-1.20],0.8962795303095351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,16064,141,0.89 [0.68-1.15],0.3740358267402417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,16089,144,0.92 [0.78-1.08],0.3069493424178299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,15563,139,0.74 [0.48-1.13],0.1644948897884732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,15529,136,0.57 [0.35-0.93],0.0243664063119215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,16098,144,0.93 [0.81-1.07],0.3082090950579189
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",15563,139,0.97 [0.63-1.48],0.8784770797133892
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,15641,140,1.28 [1.04-1.57],0.0174297463650696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,15641,140,1.10 [0.82-1.47],0.5248325709280536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,15673,134,1.00 [0.83-1.20],0.9850576595140844
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",15673,134,0.95 [0.69-1.31],0.7649008257187022
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,16064,141,1.08 [0.72-1.61],0.7050918193436447
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,18216,160,0.94 [0.76-1.17],0.5979648334434071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,18530,168,0.81 [0.60-1.10],0.1822865225854409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,15598,136,1.18 [0.87-1.58],0.2859473020687247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,15563,139,1.19 [0.91-1.56],0.2076491123337311
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,15738,143,1.11 [0.94-1.32],0.2070223275020349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,18550,167,1.32 [1.02-1.71],0.0357181521938234
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,18107,161,1.00 [0.76-1.31],0.9839238841054458
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,15563,139,0.77 [0.56-1.06],0.1040439623924021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,15673,134,0.94 [0.82-1.08],0.3927825080287889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,18297,164,1.28 [1.03-1.59],0.0254971239795292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,16032,144,1.07 [0.81-1.41],0.6520452823945084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,18528,166,1.07 [0.84-1.35],0.581966366057849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,15577,137,1.01 [0.75-1.34],0.9621427308715969
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,15612,139,1.38 [1.05-1.82],0.0228850967771287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,15738,143,0.83 [0.40-1.76],0.6334083277020011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,18107,161,1.09 [0.86-1.40],0.4696559742084414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,15998,144,0.91 [0.63-1.33],0.6412539246618498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,16058,142,0.82 [0.50-1.36],0.4489016489522126
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",16064,141,0.83 [0.59-1.15],0.2629250943082369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,18574,169,1.42 [0.86-2.35],0.1686387444312811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,18216,160,1.20 [0.96-1.49],0.1037746737658401
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,18617,166,0.86 [0.56-1.31],0.4898486879267375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,18530,168,0.79 [0.48-1.31],0.3542322674350175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,18697,171,1.11 [0.77-1.58],0.5786589266437876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,18485,168,1.03 [0.88-1.20],0.756502341195707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,18589,167,0.93 [0.82-1.06],0.2964654963913989
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,18216,160,1.18 [0.94-1.48],0.1526141225352628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,18499,168,1.34 [0.93-1.91],0.1143216230645305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,16036,144,1.97 [1.29-3.00],0.0017572996408867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,18701,165,1.22 [0.75-1.99],0.4148052133825123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,18133,164,1.09 [0.90-1.33],0.3640668172139675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,16032,144,1.03 [0.80-1.33],0.8171413599314576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,15575,137,1.15 [0.73-1.80],0.5531092415188402
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,16036,144,0.87 [0.72-1.04],0.1336054966619556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",18107,161,1.06 [0.89-1.25],0.5145804843422476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,15563,139,0.84 [0.52-1.33],0.4476325887435474
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,15563,139,0.83 [0.63-1.09],0.1735406589010804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,15604,137,0.92 [0.55-1.54],0.7596099246565174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,18507,165,1.65 [1.08-2.53],0.02104326542215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,18574,169,1.40 [0.93-2.09],0.105327110600528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,15604,137,0.75 [0.55-1.02],0.0700551321932125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,15604,137,1.32 [0.89-1.97],0.1694042009413111
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,18080,163,1.39 [1.07-1.83],0.0155662356403864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,15807,138,0.67 [0.51-0.89],0.006269052983071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,18574,169,0.71 [0.51-0.98],0.0396944182350147
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,18589,167,1.30 [0.82-2.06],0.2588912538991575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,16032,144,0.93 [0.80-1.09],0.3854467798661366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,16064,141,0.97 [0.48-1.98],0.9401788721952008
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,16110,145,0.82 [0.65-1.05],0.1122806803482705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,18751,169,1.70 [1.07-2.69],0.0245873501428011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,15604,137,0.98 [0.80-1.19],0.8342545143245896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",18524,168,0.97 [0.85-1.12],0.7145433805199638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",18216,160,0.88 [0.69-1.12],0.3104548697289578
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,15641,140,0.97 [0.78-1.21],0.795326186607729
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,16064,141,0.93 [0.63-1.38],0.7155100870598767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,15563,139,0.94 [0.75-1.17],0.5778270100050498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,15807,138,0.80 [0.55-1.17],0.2588520580967675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,18107,161,1.50 [1.15-1.95],0.0026685370422002
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",16036,144,0.93 [0.80-1.09],0.3808745545379275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,15563,139,0.87 [0.68-1.12],0.2822326353793156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,15563,139,1.38 [1.02-1.88],0.0376500153313573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,18379,166,0.90 [0.30-2.76],0.8568622634213243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,16089,144,1.52 [1.00-2.30],0.0494824849376309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,16058,142,1.34 [0.69-2.58],0.3884544251373778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,15369,139,2.56 [1.50-4.38],0.0005804617241213
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,18561,164,0.94 [0.64-1.38],0.7593352164651616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,18530,168,0.94 [0.78-1.14],0.5419267917166333
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,18107,161,1.12 [0.88-1.41],0.3497722325945465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,15641,140,0.81 [0.57-1.15],0.23335153046762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,16028,143,0.90 [0.72-1.13],0.3592980907260781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,15673,134,0.86 [0.64-1.15],0.3176324834297303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,15598,136,0.69 [0.44-1.07],0.0967687716620314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,15604,137,1.81 [0.92-3.55],0.0837159119643508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,18528,166,1.07 [0.60-1.90],0.8266762348849345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,15966,144,0.97 [0.77-1.21],0.7845145771771965
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,18379,166,1.18 [1.01-1.38],0.0335837412359299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,15529,136,1.06 [0.71-1.59],0.7826147038134761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,16064,141,0.98 [0.77-1.26],0.8881992454951441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,18530,168,1.38 [0.77-2.47],0.2858295607295377
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,15563,139,0.92 [0.78-1.09],0.3268136394361932
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",18133,164,1.42 [1.14-1.75],0.001499868492758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",15563,139,0.76 [0.49-1.18],0.2172743606961504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",18133,164,1.93 [1.70-2.19],5.9415557588416204e-24
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,18759,168,4.62 [2.01-10.60],0.000302644664634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,16098,144,1.75 [0.87-3.53],0.1163737031915149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,18759,168,1.45 [0.96-2.18],0.0750519641052215
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,15831,138,2.24 [1.47-3.43],0.0001978574270534
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,18528,166,1.66 [1.13-2.43],0.0091851200662674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,15604,137,1.04 [0.64-1.70],0.8610522499201497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,15604,137,0.89 [0.75-1.07],0.2113932950695394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,16089,144,1.14 [0.81-1.61],0.4546639592207305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,18197,158,1.11 [1.00-1.23],0.0400851647346837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,18524,168,1.28 [1.00-1.65],0.0480345443549666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,15563,139,0.80 [0.51-1.24],0.3222518193706795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,18107,161,1.01 [0.84-1.20],0.9458024397774024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,18530,168,0.74 [0.53-1.05],0.0908187210073649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,16098,144,0.73 [0.45-1.16],0.1824432701242891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,18528,166,0.99 [0.66-1.48],0.9594094760559042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,18701,165,0.90 [0.73-1.11],0.3283479001198877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,18528,166,1.81 [1.14-2.90],0.0126914259192781
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,16110,145,0.90 [0.76-1.08],0.2555873335273267
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,16064,141,0.64 [0.36-1.13],0.1258436201902681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,18650,166,1.50 [0.91-2.49],0.1105110035815605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,18530,168,1.82 [1.17-2.83],0.008187587878203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,18216,160,1.29 [1.02-1.64],0.0348578278229067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,15673,134,0.82 [0.49-1.39],0.4673264495628468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,18697,171,0.89 [0.72-1.10],0.2625748436216708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",16089,144,0.95 [0.76-1.18],0.6468213524458086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,16058,142,1.22 [0.76-1.96],0.4205944322539696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,18487,168,0.90 [0.77-1.06],0.2010433797852039
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,18574,169,0.95 [0.73-1.23],0.7049382467169383
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,18524,168,0.84 [0.56-1.25],0.378250268329255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,18107,161,1.36 [1.02-1.81],0.0333065020211912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,18528,166,0.84 [0.49-1.45],0.5332969615509101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,18697,171,0.71 [0.38-1.35],0.2985508001868978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,18528,166,1.21 [1.08-1.35],0.0008246105939047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,18524,168,0.96 [0.81-1.13],0.5887636357822248
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,16032,144,1.02 [0.87-1.19],0.7947811309719242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,18673,165,1.13 [0.78-1.63],0.5149410151759876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,18751,169,1.00 [0.81-1.24],0.9945483297200334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,15641,140,1.06 [0.57-1.99],0.8501159282211883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,15563,139,1.15 [0.87-1.52],0.32446610039518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,16011,144,0.94 [0.78-1.13],0.4922249252958063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],18440,167,0.83 [0.65-1.07],0.1506692703798574
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,18530,168,1.04 [0.79-1.37],0.7682172588749037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,15604,137,0.89 [0.73-1.08],0.2278914374893491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,15563,139,0.88 [0.51-1.52],0.6585066686010681
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,15563,139,0.62 [0.34-1.13],0.1217609954046963
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,18133,164,0.82 [0.56-1.18],0.2800603494220769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,15604,137,0.73 [0.42-1.25],0.2531913783210541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,18320,165,0.96 [0.75-1.22],0.723127845372808
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,16064,141,1.37 [0.97-1.95],0.0762214712613313
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,18103,164,0.81 [0.61-1.08],0.1551635061683423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,15807,138,1.30 [1.08-1.57],0.0063032619515934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,16036,144,1.00 [0.80-1.26],0.9772860020955472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,18440,167,1.77 [1.18-2.65],0.0059527506149088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,18530,168,1.18 [0.86-1.62],0.3166205970316503
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,15807,138,0.94 [0.72-1.23],0.6596255143163348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,15147,139,0.90 [0.79-1.02],0.1020573930861644
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,18345,165,0.95 [0.75-1.20],0.6645668086887131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,18589,167,0.90 [0.65-1.26],0.551235140003397
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,18440,167,0.82 [0.67-1.00],0.050201796965584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,15598,136,0.80 [0.54-1.18],0.2570443180891061
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,16058,142,0.91 [0.78-1.05],0.192496749658079
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,15641,140,0.92 [0.72-1.17],0.5073565529181958
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,18440,167,0.90 [0.66-1.24],0.5324808744987153
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,16052,144,4.02 [1.99-8.09],9.857137374321972e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,16058,142,1.51 [1.19-1.92],0.0008366238175131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,18528,166,1.82 [1.22-2.72],0.0034070439666445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,18430,167,1.03 [0.84-1.25],0.8045122099200934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,18650,166,1.68 [0.83-3.41],0.1466440793608508
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,15673,134,0.72 [0.45-1.17],0.1886540139529144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,15598,136,0.70 [0.47-1.05],0.0817361889563228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,16036,144,0.88 [0.66-1.16],0.358219808763389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,16064,141,0.76 [0.58-0.99],0.0428784610316647
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",15641,140,1.04 [0.83-1.31],0.7340197529304875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,18697,171,0.99 [0.90-1.09],0.8456213615279773
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,18431,168,0.71 [0.50-1.01],0.0586805742616754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,15563,139,0.79 [0.60-1.04],0.0948022695615459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,18216,160,1.10 [0.89-1.36],0.3692463477387172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,18103,164,0.94 [0.78-1.14],0.5471269400216485
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,18379,166,1.14 [1.01-1.29],0.0324699550767077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,16064,141,0.98 [0.85-1.13],0.7817064139308552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",15807,138,0.90 [0.64-1.26],0.5454180385443006
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,18197,158,1.10 [0.86-1.42],0.4352481428546867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,15641,140,0.97 [0.65-1.44],0.8776062816320954
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,15502,136,1.08 [0.80-1.46],0.6205156724282672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,18133,164,0.83 [0.65-1.05],0.1176464291768107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,15604,137,1.23 [0.86-1.77],0.2572882663262541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,15939,144,1.11 [0.67-1.87],0.681102166356981
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,16058,142,1.39 [0.93-2.06],0.1060634810954557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,15563,139,0.96 [0.77-1.21],0.7534819545478947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,18677,167,1.12 [0.68-1.84],0.6493042964119888
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,18530,168,0.61 [0.37-1.02],0.0602607146999738
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,18216,160,0.78 [0.58-1.05],0.1016384450039346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,15807,138,1.06 [0.87-1.31],0.5461540427222012
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,18530,168,0.96 [0.73-1.25],0.7555028799252863
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,18524,168,1.29 [1.08-1.53],0.004625299932788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,15738,143,1.06 [0.74-1.51],0.7471084686550813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,15529,136,0.99 [0.58-1.67],0.9588101528926312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,18133,164,0.83 [0.63-1.10],0.2034216327719127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,16036,144,1.18 [0.71-1.95],0.5297272491210674
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,15598,136,0.92 [0.74-1.15],0.4667675507664705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,15703,143,0.91 [0.64-1.29],0.5776571777435842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,16064,141,0.86 [0.68-1.07],0.174051553820051
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,18686,169,1.05 [0.55-2.01],0.8887530363978873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,16064,141,0.94 [0.50-1.78],0.8563429403682732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,18528,166,1.50 [1.05-2.16],0.0269771908969541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,16036,144,0.88 [0.54-1.43],0.6116402022142293
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,16036,144,1.57 [0.97-2.53],0.0663112859189716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,16032,144,1.24 [0.85-1.81],0.2690369947261246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,15529,136,0.92 [0.70-1.21],0.5677193712407174
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,16032,144,1.14 [0.84-1.56],0.4035243132264356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,18759,168,0.85 [0.61-1.20],0.3559582443968028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,16036,144,0.89 [0.72-1.10],0.2897282704137974
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,16089,144,0.93 [0.79-1.10],0.387783368213592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,18668,164,5.28 [4.38-6.37],2.507286980722216e-68
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,18440,167,1.61 [1.06-2.43],0.0252491862699451
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,18697,171,0.96 [0.76-1.22],0.7518750638338937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,18528,166,1.07 [0.87-1.31],0.5326432178624746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,15529,136,0.79 [0.54-1.14],0.2084018697446285
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",15529,136,0.76 [0.52-1.12],0.165761416018851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",15563,139,0.90 [0.66-1.21],0.4789569906423131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",15738,143,0.89 [0.77-1.04],0.1403459617514257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,18759,168,0.89 [0.74-1.08],0.2410220829724877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,18589,167,0.93 [0.79-1.08],0.3370043502003071
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,18107,161,1.24 [0.75-2.06],0.4040708163516955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,18528,166,1.49 [0.92-2.41],0.1010573631619406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,18759,168,1.25 [0.84-1.86],0.2623713223081753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,15529,136,0.87 [0.57-1.35],0.5440558380402873
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,15738,143,1.49 [0.84-2.65],0.1772569141792058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,16098,144,0.96 [0.74-1.24],0.7404468139015549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,15529,136,1.02 [0.78-1.34],0.8952144662770416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,16064,141,0.94 [0.82-1.08],0.3746789617470349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,18589,167,0.97 [0.87-1.08],0.5942467871918381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",18107,161,1.04 [0.79-1.37],0.8006713488379289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,15673,134,0.92 [0.66-1.30],0.6466028537485101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,15529,136,0.68 [0.42-1.09],0.1113263696154464
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,15563,139,1.08 [0.82-1.42],0.5620156163902482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,15604,137,1.03 [0.71-1.50],0.8625018826679128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,18759,168,0.85 [0.47-1.53],0.5835880874631583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,18530,168,0.97 [0.76-1.23],0.7753898985415902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,18530,168,0.89 [0.57-1.40],0.6132155152140357
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,15641,140,1.02 [0.56-1.84],0.952092375219403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,15738,143,0.70 [0.40-1.22],0.2126258118428055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,16110,145,0.76 [0.41-1.40],0.380606662603359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,15604,137,0.91 [0.80-1.05],0.1996038644973191
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,15989,143,0.98 [0.83-1.15],0.7813704319853
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,18133,164,0.88 [0.69-1.14],0.3344662953029116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,15529,136,0.91 [0.66-1.27],0.5947102548688372
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,15673,134,0.94 [0.72-1.24],0.6825560311826188
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",18414,167,0.98 [0.82-1.17],0.8292467509518829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,16110,145,1.23 [0.99-1.51],0.059402400779288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",16089,144,1.02 [0.75-1.38],0.9096280673692716
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,18751,169,2.17 [1.39-3.39],0.0007024209308309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,18668,167,1.38 [1.03-1.86],0.0323102548901548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,15913,140,0.92 [0.53-1.60],0.7679455341339487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,15563,139,0.83 [0.60-1.15],0.2720027438178042
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,15673,134,1.27 [1.04-1.54],0.0182208851046038
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,15604,137,1.00 [0.85-1.18],0.996352897295769
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,16064,141,0.89 [0.77-1.02],0.0916635856797044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,16036,144,1.12 [0.82-1.52],0.4821449339104043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,15529,136,1.04 [0.88-1.23],0.65079372108789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,18379,166,1.27 [0.80-2.04],0.3109437877989419
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,15738,143,0.85 [0.58-1.24],0.3994514425553646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,16110,145,0.62 [0.32-1.19],0.1510907296058476
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PI3,Elafin,18289,165,1.16 [0.91-1.48],0.2182656360059928
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",16064,141,0.89 [0.72-1.10],0.2765806081939492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,18299,163,1.16 [0.79-1.68],0.4540870100008896
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,18524,168,1.11 [0.89-1.38],0.367053497854069
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,18530,168,1.78 [1.15-2.76],0.0095601810857475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,15604,137,0.85 [0.62-1.18],0.3340678576429358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,18530,168,1.51 [1.08-2.09],0.014656248836319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,18528,166,1.37 [1.06-1.78],0.0146459339873259
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,15738,143,0.86 [0.69-1.08],0.1956710735726519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,15502,136,1.00 [0.80-1.24],0.968595912675019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,16089,144,1.31 [0.72-2.41],0.378000423778338
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,15563,139,1.19 [0.92-1.54],0.1916843873633895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,18533,166,0.96 [0.77-1.19],0.6980002201707336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,15807,138,1.06 [0.85-1.32],0.5899112767522343
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,18379,166,0.99 [0.78-1.26],0.9282855145845228
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,18574,169,1.49 [0.91-2.42],0.1098798724284292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,18734,168,1.19 [0.88-1.62],0.2550174312075874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",18514,167,1.22 [0.97-1.53],0.0871642180491489
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,18589,167,0.96 [0.82-1.12],0.6236068974460305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,18530,168,1.09 [0.72-1.66],0.6795100017434992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,18698,167,0.63 [0.49-0.81],0.0003928607544755
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,18530,168,1.34 [0.90-1.99],0.1439259258524328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,18383,164,2.67 [1.69-4.20],2.4094071356835923e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",16058,142,0.73 [0.56-0.94],0.0168682980418386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",15604,137,1.17 [0.82-1.67],0.3909499284177765
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",16058,142,0.91 [0.77-1.06],0.2293077667952067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,16058,142,0.99 [0.78-1.24],0.9124575018947978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,15715,139,1.08 [0.50-2.33],0.8364314882809344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,18133,164,0.89 [0.59-1.35],0.5859662900155636
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,18528,166,0.88 [0.63-1.23],0.4514131994393527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,18528,166,0.88 [0.71-1.08],0.2162893271253778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,16030,142,0.98 [0.73-1.30],0.8632989861616195
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,18701,168,1.06 [0.74-1.53],0.7529063117487922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,18107,161,0.97 [0.63-1.49],0.876354186637991
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,16058,142,0.57 [0.30-1.06],0.0737874882780358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,18524,168,0.91 [0.77-1.08],0.2927507613590582
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,18675,167,2.12 [1.26-3.59],0.0049777971950673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,18466,165,0.85 [0.64-1.14],0.2855666975211244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,18451,165,1.03 [0.95-1.10],0.4892783382395527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,15563,139,1.01 [0.83-1.23],0.9187878527114116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,15563,139,0.85 [0.65-1.13],0.2747170916608679
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,15673,134,0.99 [0.72-1.38],0.9715307693109037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,18105,164,0.98 [0.86-1.11],0.7146980648901471
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,16110,145,1.04 [0.81-1.32],0.7724547270431602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,16058,142,1.07 [0.88-1.30],0.4758336165402542
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,18498,166,1.01 [0.97-1.06],0.5462554954871206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,15641,140,1.08 [0.82-1.43],0.5899076578241594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,15598,136,0.99 [0.68-1.43],0.9386092136097336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",18216,160,0.96 [0.84-1.09],0.4922863593368617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,18440,167,0.37 [0.15-0.90],0.0286849923497871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,18574,169,0.75 [0.46-1.21],0.2375008783849055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,15604,137,1.38 [1.02-1.86],0.036681483462737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,15604,137,1.03 [0.59-1.80],0.909434570318302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",18440,167,1.55 [1.17-2.05],0.0020990845827304
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,15641,140,0.80 [0.63-1.01],0.0563043225390841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,16110,145,0.78 [0.45-1.37],0.3916850836371887
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,18197,158,0.85 [0.57-1.27],0.4333978949784121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,18589,167,0.84 [0.55-1.27],0.4048020657500399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,16098,144,0.92 [0.60-1.41],0.7060609419621775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,15987,142,0.91 [0.76-1.10],0.3496537523101617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,18697,171,0.92 [0.68-1.23],0.5555624542171634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,18539,165,0.93 [0.81-1.07],0.3271680885214047
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,15807,138,0.99 [0.76-1.30],0.9423986593751784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",16098,144,0.84 [0.64-1.10],0.1988452397241778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,15604,137,0.96 [0.57-1.61],0.8665379296851347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,18107,161,0.96 [0.61-1.51],0.8582745727975266
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,15604,137,0.88 [0.65-1.20],0.413251694728776
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,16089,144,0.89 [0.66-1.20],0.4389403829381879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,18440,167,0.83 [0.66-1.05],0.1137171347981955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,16032,144,0.86 [0.70-1.04],0.1219462493920322
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,18574,169,0.96 [0.83-1.11],0.5766098461227572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,15807,138,1.04 [0.83-1.30],0.7310427185940513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,16064,141,0.83 [0.67-1.03],0.09200857833302
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,16064,141,1.15 [0.78-1.69],0.4702821890005139
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,18528,166,0.92 [0.78-1.10],0.3765242517188366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,18751,169,0.99 [0.86-1.15],0.9150181071006712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,16036,144,0.98 [0.86-1.12],0.7741919819619336
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,18379,166,1.19 [0.85-1.66],0.3097505206224784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,15673,134,0.98 [0.78-1.22],0.8400054731624709
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,18464,168,0.95 [0.83-1.09],0.4722790408658864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,18107,161,1.28 [1.07-1.54],0.007116579619793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,15529,136,1.12 [0.59-2.13],0.7175025858987096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,16098,144,1.02 [0.67-1.54],0.9376657062720128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,16032,144,0.81 [0.52-1.26],0.3391927192303243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,18640,166,1.77 [1.17-2.67],0.0064689996763526
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,18000,160,1.03 [0.88-1.20],0.6913646479541677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,15848,143,0.94 [0.73-1.23],0.6677325746518576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",18216,160,1.07 [0.88-1.29],0.5110383278056247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",18751,169,0.90 [0.74-1.09],0.2859652523263924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,18701,165,0.89 [0.71-1.12],0.3264475658612429
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,18216,160,1.13 [0.70-1.83],0.6148925789032917
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,18498,166,1.21 [0.66-2.22],0.5437669682779668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,16098,144,1.15 [0.85-1.57],0.3673902476650914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,16098,144,0.82 [0.59-1.14],0.2345914023114642
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,18216,160,1.04 [0.80-1.34],0.779094168924141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,15673,134,0.97 [0.57-1.65],0.9017738685565349
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,18528,166,0.88 [0.75-1.04],0.1288760890029319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,16024,142,0.93 [0.76-1.15],0.5185014639484473
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,18216,160,0.76 [0.53-1.10],0.1476475421911711
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,15563,139,0.84 [0.55-1.28],0.4107851742149512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,15738,143,0.91 [0.80-1.03],0.1391295275586846
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,18107,161,1.06 [0.86-1.30],0.6018655845410754
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,18697,171,1.05 [0.88-1.26],0.5843603174023683
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,16058,142,1.08 [0.78-1.51],0.6437149256054203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,18594,165,0.64 [0.37-1.10],0.1043637386944907
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,15563,139,0.99 [0.60-1.62],0.9653013384608992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,18524,168,0.91 [0.69-1.20],0.5189072366913423
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,16113,144,0.73 [0.39-1.36],0.3259496207486602
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,15628,143,1.19 [0.96-1.48],0.1137241267110223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,15604,137,1.07 [0.76-1.52],0.6891579334300664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,15641,140,1.65 [1.09-2.50],0.019022428988821
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,18617,166,1.17 [0.93-1.48],0.1764043110104977
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,15604,137,1.08 [0.67-1.72],0.761355943745494
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,18467,165,0.85 [0.60-1.20],0.3488635847792398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,16058,142,1.11 [0.73-1.67],0.6293267474255025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,18445,165,1.12 [0.80-1.56],0.521376007692725
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,18133,164,0.95 [0.84-1.07],0.3853016873677468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,18701,165,0.67 [0.40-1.13],0.1293567837297795
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,18069,161,1.45 [1.16-1.81],0.0009686336366905
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,15807,138,0.69 [0.37-1.28],0.2405154179834346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,15956,140,2.00 [1.20-3.34],0.0080822167167405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,16036,144,1.06 [0.77-1.46],0.7282440977324294
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,16036,144,1.04 [0.97-1.10],0.259713866753416
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,18379,166,0.99 [0.88-1.12],0.8909956575871947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,18524,168,1.16 [0.96-1.40],0.1192745228025518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,18107,161,0.98 [0.72-1.34],0.8843828960303498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,15529,136,0.77 [0.44-1.34],0.3600456389431106
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,16064,141,1.19 [0.88-1.60],0.2611156791096783
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,15673,134,0.84 [0.59-1.20],0.3384282024467268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,18440,167,0.90 [0.70-1.16],0.4019602460712175
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,18349,166,1.04 [0.71-1.51],0.8434124410999704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,18304,166,1.06 [0.72-1.56],0.7598958214142044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,18524,168,0.95 [0.72-1.24],0.7004422888404216
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,15604,137,0.95 [0.71-1.28],0.7457269882011432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,18524,168,0.94 [0.80-1.09],0.3945945493010165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,18107,161,0.97 [0.77-1.23],0.7956840369168903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,15181,140,0.89 [0.77-1.03],0.1149126179540707
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",18133,164,1.05 [0.67-1.66],0.8314606666670404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,18417,162,1.72 [1.16-2.55],0.0075353439700569
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,15491,137,0.83 [0.61-1.13],0.2422441679278583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,16089,144,0.81 [0.67-0.98],0.0330898169395793
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,15673,134,0.90 [0.73-1.11],0.331152487071066
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,18524,168,0.71 [0.46-1.11],0.1319741398445084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,18133,164,1.23 [0.85-1.78],0.2789222591257368
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,18197,158,0.94 [0.70-1.25],0.6592050349403544
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,15604,137,1.12 [0.83-1.51],0.4729958174323289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,18379,166,1.13 [0.95-1.34],0.1589989835632667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,18567,166,0.94 [0.81-1.09],0.4393648689183563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,15576,135,0.86 [0.54-1.35],0.5124119974576387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,16089,144,0.87 [0.51-1.49],0.606513769214822
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,16098,144,5.44 [3.31-8.94],2.1629834709253904e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,18759,168,1.31 [0.81-2.10],0.2701450471936359
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,16036,144,1.63 [1.21-2.19],0.0013116855845238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,16036,144,1.66 [0.88-3.11],0.1162280004458258
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,18492,168,1.07 [0.61-1.88],0.8095800067731346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,18318,166,1.02 [0.67-1.54],0.941136357442245
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,16058,142,0.84 [0.55-1.30],0.4342340897543021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,18759,168,1.62 [0.95-2.77],0.0768177803125129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,16089,144,0.93 [0.55-1.56],0.7793645015386487
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,15738,143,0.82 [0.62-1.08],0.1524871862478152
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,18038,162,1.08 [0.84-1.40],0.5296108031690915
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,15807,138,1.15 [0.79-1.66],0.4694177020925019
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,18524,168,1.24 [0.92-1.67],0.1555271316433924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,18626,165,0.90 [0.80-1.01],0.0686661891132809
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,18697,171,0.86 [0.59-1.24],0.4154182814804252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,16032,144,1.18 [0.94-1.47],0.1550171421981087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,18133,164,1.23 [0.97-1.56],0.0815341538189837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,15641,140,1.37 [0.97-1.95],0.0729888716798492
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,15563,139,1.00 [0.85-1.18],0.968717788213899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,16113,144,2.06 [1.39-3.05],0.000294851916044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,18435,165,0.93 [0.67-1.29],0.6600419094593801
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,18541,165,2.55 [1.54-4.23],0.0002840329140305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,15790,140,1.39 [1.07-1.79],0.0124286883767334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,16089,144,0.87 [0.64-1.18],0.3642376887185937
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,16089,144,0.93 [0.80-1.08],0.3215908448857805
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,16089,144,0.86 [0.72-1.04],0.1206979930336922
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,16032,144,0.83 [0.63-1.08],0.1696296769702337
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,15563,139,0.94 [0.73-1.20],0.604452427489004
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,18216,160,0.95 [0.79-1.14],0.5617312904579737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,15563,139,1.03 [0.87-1.22],0.7319444319565144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,15598,136,1.14 [0.90-1.44],0.2685973268611789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,16032,144,1.16 [0.87-1.55],0.30334161973099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,18524,168,0.89 [0.65-1.21],0.45247269582328
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,18133,164,0.93 [0.68-1.25],0.6210616307232404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,15738,143,0.92 [0.74-1.14],0.45791808059134
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,18107,161,0.84 [0.65-1.10],0.2027139425450686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,18216,160,0.97 [0.77-1.24],0.8223793632312202
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,15673,134,0.99 [0.77-1.27],0.911859866374118
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,18107,161,0.96 [0.71-1.31],0.8107584435338173
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,15807,138,1.02 [0.76-1.38],0.8910750277330876
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,15604,137,0.98 [0.56-1.70],0.9402730528879945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,16032,144,1.23 [0.93-1.62],0.1505006134746618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,15641,140,0.78 [0.56-1.07],0.1175404751325223
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,15598,136,0.73 [0.44-1.24],0.2457739945526262
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,18107,161,1.02 [0.76-1.37],0.8750380829352904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,15604,137,0.94 [0.72-1.22],0.6220011497653475
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,15807,138,0.81 [0.58-1.12],0.2044855459709929
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,18107,161,0.96 [0.61-1.49],0.8490129335019025
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,18650,166,0.86 [0.65-1.15],0.3121674527104588
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,18133,164,1.23 [0.84-1.82],0.2846053772431172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,15529,136,0.75 [0.50-1.12],0.1552347917066775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,18107,161,1.24 [1.02-1.51],0.029087424798414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,16064,141,1.56 [1.12-2.16],0.0079647259809348
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,18107,164,1.17 [0.89-1.54],0.2615318145108243
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,16064,141,0.80 [0.64-0.99],0.0442628035263437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,15563,139,0.98 [0.68-1.42],0.933051441713084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,15529,136,0.84 [0.58-1.23],0.3671776684742058
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,15673,134,1.11 [0.90-1.37],0.3176837815797028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,18440,167,1.13 [0.95-1.34],0.1700792915565209
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,18440,167,1.31 [1.04-1.67],0.0246805156498491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,16036,144,1.15 [0.91-1.46],0.2368553866074978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,15604,137,0.98 [0.75-1.26],0.8526317358504182
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,15641,140,0.92 [0.78-1.08],0.2980774730386225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,16032,144,1.11 [0.83-1.48],0.4958775166164951
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,18197,158,1.30 [1.00-1.67],0.0475432836048751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,15641,140,0.81 [0.38-1.72],0.5753115974180883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,16064,141,0.86 [0.65-1.13],0.2796735445397366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,18438,162,1.34 [1.03-1.73],0.0278578459002957
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,18759,168,1.22 [0.98-1.53],0.0792932009238459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,18759,168,1.22 [1.00-1.49],0.0543866681327629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,16032,144,1.04 [0.69-1.55],0.8611912696820238
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,18528,166,1.16 [0.89-1.51],0.2621085561768732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,15604,137,1.06 [0.76-1.49],0.7188838737357596
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,18530,168,2.28 [1.51-3.43],7.78993179458739e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REN,Renin,18528,166,0.94 [0.79-1.11],0.4714839879508994
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,15604,137,0.99 [0.65-1.52],0.9769606953935712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,15529,136,0.80 [0.49-1.32],0.3838546017950355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,18440,167,0.70 [0.49-1.01],0.058963170328881
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RETN,Resistin,18494,165,1.34 [0.99-1.80],0.0555697755803761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",15563,139,0.49 [0.30-0.80],0.0044590080521307
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,16032,144,1.46 [0.74-2.88],0.2756755499760351
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,16064,141,0.83 [0.68-1.03],0.093028524221085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,15807,138,0.85 [0.63-1.14],0.2709535294015519
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,18697,171,0.84 [0.55-1.29],0.431744890034646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,18697,171,1.03 [0.63-1.68],0.9051678715942136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,16064,141,0.78 [0.59-1.03],0.0831910933480946
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,18216,160,1.06 [0.86-1.29],0.5904161479334288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,18284,166,1.00 [0.89-1.12],0.971240945944023
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,15604,137,0.87 [0.59-1.29],0.4955444598962767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,15738,143,1.10 [0.80-1.52],0.5479845883225807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,18652,165,0.90 [0.72-1.14],0.3951323069202378
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,16089,144,0.89 [0.76-1.05],0.169448403954842
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,15563,139,1.01 [0.80-1.29],0.9124769497609088
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,16064,141,1.10 [0.81-1.50],0.5371430331384448
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,15713,142,1.00 [0.73-1.37],0.9854229496443614
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,16110,145,1.66 [0.95-2.89],0.0752681125627405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,15641,140,1.20 [0.87-1.67],0.2683432099035978
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,18438,165,0.98 [0.87-1.11],0.7847260922622099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,15602,141,1.48 [0.84-2.60],0.1708256488962939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,16002,144,1.85 [1.42-2.40],4.528871694024744e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,16064,141,0.76 [0.52-1.10],0.1491415010754306
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,18672,166,2.90 [1.87-4.51],2.1680233193862824e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,15641,140,2.78 [1.76-4.41],1.237793791050864e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,15604,137,1.12 [0.76-1.64],0.5702540344784779
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,15604,137,1.28 [0.89-1.84],0.1859541885340851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,15807,138,0.86 [0.65-1.13],0.2735221923914371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,18107,161,1.24 [1.01-1.52],0.0363618825394281
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,15807,138,0.91 [0.66-1.25],0.5671771084292919
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,15641,140,0.92 [0.74-1.15],0.4758713485302018
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,18528,166,3.34 [1.99-5.60],5.168508515726097e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,18697,171,1.19 [0.66-2.17],0.5620379698054723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,15641,140,1.89 [0.77-4.64],0.1627760585236617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,18528,166,1.68 [1.10-2.58],0.0172285549162029
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,18440,167,1.03 [0.75-1.42],0.8470177610416082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,15604,137,0.98 [0.57-1.68],0.9312241833608564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,15807,138,0.99 [0.79-1.24],0.9322030927865737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,15673,134,1.02 [0.68-1.54],0.9301104382837798
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,15641,140,1.67 [1.23-2.27],0.0010514317115825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,15563,139,1.01 [0.68-1.50],0.9581476706241442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,15673,134,0.97 [0.85-1.10],0.626130425838671
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,18107,161,1.77 [1.50-2.08],1.035888952033823e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,18107,161,0.99 [0.81-1.22],0.9508684829654456
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,15598,136,0.89 [0.74-1.07],0.2023355378526233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,18379,166,1.04 [0.69-1.56],0.862253237553889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,18701,165,1.36 [0.83-2.22],0.2168004145748292
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,18440,167,0.75 [0.46-1.21],0.2385588372330272
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,15563,139,1.09 [0.80-1.47],0.5904290199911811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",16064,141,0.88 [0.74-1.05],0.1549347721607252
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,18701,165,0.89 [0.59-1.36],0.5898498982723284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,18107,161,1.02 [0.89-1.17],0.7925334189457813
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,18697,171,0.99 [0.80-1.23],0.9306057549284046
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,15563,139,0.69 [0.40-1.20],0.1889536185624543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,18392,165,1.11 [0.85-1.45],0.4481690561554751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,18260,165,1.14 [0.95-1.37],0.160609853351387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,15604,137,1.09 [0.69-1.74],0.7143765957780557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,16064,141,1.17 [0.87-1.58],0.2848732498523217
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,18103,164,0.96 [0.76-1.21],0.7029051468476345
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,16032,144,1.34 [1.07-1.69],0.0106448048894255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,18574,169,0.84 [0.66-1.07],0.1692690250281095
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,16064,141,1.26 [0.94-1.71],0.1252612823939852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,18197,158,1.07 [0.83-1.36],0.608389556696288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,16113,144,0.97 [0.55-1.69],0.911374901547786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,16064,141,1.41 [0.86-2.31],0.1774154890062874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,15598,136,0.96 [0.69-1.33],0.7921981726752305
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,18524,168,0.98 [0.81-1.19],0.8447020346204396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,15807,138,0.86 [0.67-1.10],0.21781821377346
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,16039,143,0.88 [0.77-1.02],0.0952380640788667
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,15563,139,1.60 [1.26-2.03],9.895032944131474e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,15563,139,1.00 [0.72-1.40],0.9798639005853164
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,15807,138,0.89 [0.68-1.15],0.3676952931929086
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,16064,141,1.34 [0.85-2.12],0.2074236762203321
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,16067,143,0.84 [0.53-1.32],0.4429278682088371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,18440,167,1.04 [0.89-1.23],0.6049975290969374
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,18697,171,0.88 [0.56-1.38],0.5699949158742558
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,18133,164,1.07 [0.85-1.35],0.5440541179816947
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,18023,160,2.26 [1.56-3.28],1.708986300731164e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,18759,168,1.04 [0.75-1.43],0.8165135047831741
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,18697,171,1.48 [0.92-2.39],0.1026962528183044
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,18624,165,0.81 [0.53-1.24],0.3292942885407284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,18528,166,0.87 [0.58-1.32],0.5148273068085587
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,18534,165,1.20 [0.93-1.57],0.1677818804436399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,15563,139,1.01 [0.59-1.73],0.9656726787285704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,15738,143,1.95 [1.06-3.57],0.0315510578571026
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,18567,166,1.05 [0.89-1.25],0.5326494330754512
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,18216,160,1.17 [0.85-1.60],0.3335103670236404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,15598,136,0.97 [0.78-1.22],0.8232691021412999
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,18652,165,0.96 [0.71-1.28],0.7637941754824454
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,15598,136,0.82 [0.56-1.21],0.3215056700347592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,15673,134,0.60 [0.32-1.16],0.1303736353365618
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,15673,134,0.78 [0.46-1.31],0.3404669702397014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,15598,136,1.07 [0.77-1.50],0.6797028447623956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,15641,140,0.96 [0.65-1.42],0.8470146372036891
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,18107,161,0.93 [0.76-1.13],0.4711090207152437
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,15590,139,0.90 [0.65-1.26],0.5384845689710811
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,16089,144,1.24 [0.71-2.15],0.4511802152628414
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,15641,140,1.00 [0.83-1.20],0.9905259813919592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,18524,168,1.08 [0.85-1.38],0.5420796439258799
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SCT,Secretin,15673,134,0.88 [0.61-1.25],0.4691565535484275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,18528,166,1.62 [1.18-2.23],0.0030417412181845
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,18528,166,0.66 [0.49-0.87],0.0038650692114696
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,16032,144,0.95 [0.83-1.10],0.4993119975463528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,16036,144,1.01 [0.78-1.30],0.963876873891924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,15738,143,2.20 [1.65-2.92],6.05272048011459e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,15641,140,0.90 [0.73-1.11],0.3239165161702097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,15641,140,1.43 [1.01-2.03],0.0449855337978157
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,18759,168,1.16 [0.89-1.52],0.2805846075853789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,16113,144,0.51 [0.25-1.05],0.0664444887972165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,16113,144,4.33 [2.41-7.78],9.134881036193898e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,18617,166,0.79 [0.61-1.01],0.0599275683641572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,18524,168,1.17 [0.70-1.95],0.5505931988041992
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,18528,166,1.78 [1.06-2.97],0.0285354132169616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,15738,143,1.70 [1.25-2.31],0.0007149500696037
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,18440,167,1.51 [1.06-2.15],0.0239346913808469
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,18697,171,1.98 [1.26-3.12],0.0031743678597158
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,15604,137,1.16 [0.64-2.13],0.6195481095245399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,18698,167,5.77 [4.05-8.21],2.3201331303523235e-22
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,16064,141,0.93 [0.75-1.16],0.5253170447546536
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,15807,138,0.88 [0.63-1.25],0.4853644468156874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,16026,142,1.55 [1.00-2.39],0.0497471866036903
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,18440,167,1.17 [0.74-1.83],0.5022334216635358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,15817,141,3.81 [1.00-14.46],0.0495329775287255
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,18759,168,1.07 [0.77-1.48],0.7026123446954138
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,18005,158,1.05 [0.93-1.19],0.4397188452055921
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,16069,143,2.78 [1.45-5.35],0.0021430078209693
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,15821,140,0.61 [0.31-1.20],0.1531224645061911
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,15875,141,0.57 [0.31-1.05],0.0709148871277177
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,16113,144,1.05 [0.38-2.94],0.922646037024028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,16113,144,2.70 [1.19-6.11],0.0175558977091001
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,18362,167,1.62 [1.36-1.92],5.722770786970362e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,18473,166,0.98 [0.84-1.14],0.8094320958752704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,18197,158,1.12 [0.83-1.50],0.4658422920087973
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,18633,169,0.97 [0.77-1.23],0.8162206445313149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,18751,169,1.28 [1.07-1.53],0.0075678285588024
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,18379,166,1.07 [0.70-1.64],0.7457048706810032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,16086,142,2.51 [0.86-7.30],0.0906406050762334
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,16086,142,1.26 [0.72-2.21],0.4222174486938745
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,18759,168,0.84 [0.69-1.02],0.0834258728862758
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,16089,144,0.97 [0.76-1.24],0.8074678242145161
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,15874,141,1.08 [0.59-1.99],0.7968501501803364
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,15807,141,1.68 [0.51-5.55],0.3939388441731468
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,16086,142,1.27 [0.53-3.04],0.5934158740469643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,15807,138,0.95 [0.84-1.08],0.4235220124126108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,15710,142,0.94 [0.53-1.67],0.8330430782154712
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,16036,144,0.96 [0.72-1.28],0.7804679709652406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,18133,164,0.93 [0.74-1.16],0.5007978705855393
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,18309,163,1.69 [1.11-2.58],0.013799354695744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,15673,134,0.71 [0.40-1.25],0.2335167202825394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,18574,169,0.86 [0.52-1.41],0.5453397823384156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,18440,167,1.43 [0.82-2.49],0.2084880177752295
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,18440,167,0.84 [0.69-1.02],0.0776642214696804
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,18311,165,0.73 [0.52-1.03],0.0727711308468713
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,15738,143,0.88 [0.59-1.33],0.5566569382157688
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,18107,161,0.88 [0.66-1.16],0.3521803606286886
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,18107,161,1.16 [0.89-1.51],0.2785450668307028
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,18528,166,1.07 [0.87-1.30],0.5416781375747874
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,15839,142,1.00 [0.75-1.34],0.9935515438378434
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,18107,161,1.01 [0.88-1.17],0.8398260248357005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,18524,168,1.38 [1.15-1.64],0.0003819421555102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,15598,136,0.58 [0.40-0.86],0.0058219302101032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,16036,144,1.10 [0.82-1.48],0.5205894693928592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,15712,138,0.82 [0.69-0.97],0.0239998290441956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,16058,142,0.86 [0.67-1.09],0.2072278101553151
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,16110,145,1.22 [0.86-1.73],0.2649883956053807
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,15529,136,0.93 [0.79-1.08],0.3241936084795425
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,15535,139,1.09 [0.91-1.29],0.3516675413681952
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,15604,137,0.78 [0.52-1.17],0.2293549315577579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,16098,144,2.36 [1.49-3.72],0.0002321523174597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",18567,166,0.94 [0.80-1.11],0.4536108556950864
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,15807,138,1.13 [0.78-1.65],0.5219125288127491
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,18545,169,1.09 [0.81-1.46],0.5733496548584021
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,18589,167,1.50 [1.09-2.08],0.0132596456804261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,18524,168,5.31 [3.94-7.16],8.131331010842896e-28
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,18133,164,1.03 [0.86-1.24],0.7509325144624329
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,18530,168,1.01 [0.90-1.13],0.910930961487532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,18701,165,3.19 [2.24-4.54],1.3030113193678434e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,18528,166,1.13 [0.69-1.86],0.6174913525977481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,15641,140,2.09 [1.48-2.94],2.5553068377976933e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,18675,165,0.95 [0.60-1.49],0.8168256187581704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,15641,140,0.99 [0.60-1.62],0.9536820804476702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,18576,166,1.35 [1.04-1.75],0.0241874870331137
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,18464,166,1.89 [1.43-2.51],7.346578308952675e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,15604,137,0.99 [0.82-1.21],0.9441696555351244
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,18440,167,0.96 [0.82-1.12],0.6037434022290289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",18133,164,0.71 [0.52-0.97],0.029700573615335
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,18216,160,1.17 [0.91-1.51],0.2279445925135856
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,18351,166,0.88 [0.72-1.07],0.1888975672292623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,18589,167,0.92 [0.81-1.05],0.2115273628617242
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,15563,139,0.94 [0.61-1.45],0.765482327061858
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,16064,141,0.85 [0.73-0.98],0.0300360703220162
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,18216,160,1.41 [1.11-1.79],0.0055027710725131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,18107,161,2.74 [2.10-3.58],1.0433929248745544e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,18524,168,1.15 [0.91-1.45],0.2288809766491613
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,18107,161,2.56 [1.99-3.30],2.800152228359273e-13
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,15563,139,1.16 [0.66-2.04],0.6074170806494531
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,16032,144,1.02 [0.78-1.33],0.8731137197280746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,18133,164,1.02 [0.80-1.31],0.8725580089785945
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,15673,134,0.99 [0.72-1.38],0.9706081222810032
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,18133,164,1.05 [0.86-1.28],0.6321441970034136
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,15529,136,0.90 [0.66-1.21],0.4781489054970398
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,15529,136,0.78 [0.52-1.17],0.2260638159613867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,18133,164,1.27 [0.88-1.84],0.2074936276673939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,18524,168,1.05 [0.81-1.37],0.7098946694984993
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,15673,134,1.06 [0.84-1.34],0.6384459311029964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,16098,144,0.87 [0.62-1.22],0.4314342875871225
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,15563,139,0.91 [0.71-1.16],0.4441971280235594
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,15738,143,0.93 [0.77-1.12],0.4373426630478849
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,16036,144,0.95 [0.68-1.32],0.7480218066626048
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",15529,136,0.97 [0.72-1.30],0.8176516005489753
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,18133,164,1.00 [0.77-1.30],0.9925784117249988
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,15604,137,1.07 [0.64-1.77],0.8018131795590889
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,18701,165,1.61 [1.15-2.25],0.0051203130159011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,18197,158,1.17 [0.78-1.74],0.4477292371692686
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,15807,138,0.99 [0.80-1.22],0.9050723315114142
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,16036,144,0.97 [0.80-1.18],0.7548444297363205
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,15984,143,1.03 [0.67-1.61],0.8815677553516404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,18107,161,0.96 [0.81-1.13],0.5993354945428159
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,16032,144,0.85 [0.67-1.08],0.1794770609979829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,16032,144,0.94 [0.69-1.28],0.70669299235734
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,18440,167,0.45 [0.24-0.83],0.0109408485602621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,18133,164,0.98 [0.81-1.19],0.8581078134027568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,15529,136,0.97 [0.70-1.33],0.838891073089043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,16036,144,1.34 [1.11-1.61],0.0019963136473131
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,18701,165,1.50 [1.00-2.25],0.0488858620260625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,18589,167,0.99 [0.69-1.41],0.9466337959462824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,18604,171,1.28 [0.99-1.65],0.0609475379497788
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,15604,137,0.96 [0.71-1.30],0.8060005595355934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,18555,167,1.08 [0.88-1.33],0.4548303338556289
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,16032,144,1.12 [0.93-1.34],0.2283368891706605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,15598,136,0.73 [0.54-1.00],0.0498565540303156
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,16026,142,0.93 [0.77-1.12],0.4255263724180744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,18528,166,0.89 [0.76-1.03],0.1281052199791315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,15598,136,0.76 [0.53-1.08],0.1254302018330546
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,18574,169,0.94 [0.81-1.09],0.3815031045117552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,16064,141,0.92 [0.69-1.21],0.5428530227677548
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,15738,143,0.88 [0.77-1.01],0.0737235035558344
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,18379,166,1.00 [0.81-1.24],0.977086036749762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",15641,140,1.03 [0.62-1.71],0.9201512644526386
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',16058,142,1.36 [1.11-1.68],0.003485315373204
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,15563,139,1.23 [1.00-1.52],0.0542070261780882
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,15738,143,0.83 [0.62-1.13],0.242714230624299
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,16036,144,0.99 [0.69-1.43],0.9647100855393193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,16032,144,0.99 [0.82-1.19],0.9228736319499063
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,15641,140,0.97 [0.56-1.68],0.900967911753732
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,18528,166,0.89 [0.72-1.10],0.2852027511041149
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],18182,160,1.03 [0.77-1.38],0.8547417022337691
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",18530,168,1.17 [0.82-1.66],0.381026192536737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,16110,145,0.85 [0.62-1.17],0.3326124577933388
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,16064,141,0.94 [0.61-1.44],0.7758138787548102
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,18107,161,1.81 [1.23-2.67],0.0027507380698739
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,18619,165,0.98 [0.80-1.20],0.8553578081340552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,18507,165,0.97 [0.67-1.40],0.8738748984576656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,18507,165,0.80 [0.56-1.14],0.2100620095098654
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,15673,134,1.08 [0.78-1.49],0.6405817053024914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,16026,141,1.74 [1.02-2.97],0.0416256680853097
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,15673,134,1.55 [0.83-2.89],0.1661802246117319
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,16064,141,0.68 [0.38-1.22],0.1977839523242527
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,16064,141,0.98 [0.74-1.30],0.893582568111746
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,18574,169,0.88 [0.74-1.06],0.191437760318789
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,18553,166,0.94 [0.57-1.55],0.8030499250093708
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPART,Spartin,15738,143,0.86 [0.69-1.06],0.1547333959682472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,16089,144,1.18 [0.75-1.87],0.4730376970562366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,18530,168,1.51 [1.10-2.06],0.0105212747273014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,15738,143,1.35 [0.87-2.09],0.1765073338833771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,18524,168,1.10 [0.90-1.36],0.3456407449542883
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,18530,168,0.65 [0.43-0.97],0.0336279473085763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,18701,165,0.95 [0.73-1.24],0.7113684270524314
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,15563,139,0.85 [0.52-1.41],0.5355866210605673
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,18462,166,2.16 [1.33-3.53],0.0020171222052857
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,18589,167,1.13 [0.80-1.60],0.5003142972833347
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,16036,144,0.89 [0.81-0.98],0.0136565457794067
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,18379,166,0.48 [0.29-0.82],0.0074850413413705
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,18528,166,1.50 [1.00-2.26],0.0510125131664523
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,18445,164,1.14 [0.76-1.72],0.5277510034965369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,18729,168,1.22 [0.89-1.68],0.2080757672442914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",15604,137,1.00 [0.68-1.47],0.9898670076946356
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,15529,136,1.10 [0.86-1.40],0.4520856742787141
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,15807,138,1.06 [0.89-1.27],0.4994979400030237
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,16058,142,1.10 [0.85-1.41],0.4843076055249823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,18216,160,0.96 [0.82-1.12],0.5991383759002786
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",15598,136,0.52 [0.29-0.95],0.0332345855835802
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,16058,142,0.98 [0.64-1.49],0.9089719783296584
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,18545,169,0.93 [0.83-1.04],0.1841135394450435
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,18440,167,1.11 [0.89-1.38],0.3590713677250557
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,18524,168,0.97 [0.82-1.14],0.7169669276276605
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,16089,144,1.22 [0.80-1.86],0.359307557992744
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,18133,164,1.12 [0.92-1.37],0.2487492045953406
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",15604,137,0.95 [0.59-1.55],0.8466719684826571
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,18507,165,0.87 [0.78-0.98],0.02188528886763
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,18617,166,0.97 [0.70-1.34],0.8562853240974561
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,15529,136,0.80 [0.44-1.45],0.458341282399077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,16036,144,0.95 [0.69-1.30],0.7538271526640877
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,15738,143,0.85 [0.63-1.15],0.2950077672348373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",18440,167,1.22 [0.92-1.63],0.1686531781456648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",18759,168,0.96 [0.61-1.52],0.869884212990514
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",15604,137,1.13 [0.85-1.50],0.401939093101603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,16098,144,1.17 [0.66-2.08],0.5938117207609825
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,16032,144,0.88 [0.56-1.39],0.5830914047282123
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,18351,166,1.01 [0.81-1.25],0.9521298476513664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,15604,137,0.95 [0.76-1.18],0.6172376410811875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,18440,167,0.97 [0.88-1.07],0.5421395252906658
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,15529,136,1.02 [0.79-1.30],0.904602634165634
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,18697,171,1.68 [1.29-2.21],0.0001604584944404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,18508,168,1.78 [0.99-3.20],0.0526548690105301
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,15598,136,0.97 [0.77-1.23],0.8215133055759073
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,18494,167,0.92 [0.74-1.14],0.4222542778660394
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,18197,158,0.89 [0.73-1.09],0.264979356819405
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,18133,164,0.96 [0.76-1.20],0.7058700191145736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,18528,166,0.87 [0.75-1.02],0.0891421690740481
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",15529,136,1.03 [0.86-1.22],0.7552734074293239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,18107,161,1.01 [0.79-1.29],0.9229630720406774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,15673,134,0.96 [0.62-1.47],0.834443812741396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,16058,142,0.94 [0.61-1.45],0.7689915262224096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,18440,167,1.04 [0.84-1.30],0.7024951386896072
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,15604,137,0.96 [0.62-1.47],0.8452372130655298
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,18107,161,1.09 [0.89-1.34],0.3914150610370972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,15604,137,1.09 [0.78-1.53],0.6254500140339432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,18524,168,0.96 [0.72-1.29],0.8082784133965895
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,16064,141,0.84 [0.68-1.03],0.0923149528983087
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,18107,161,1.17 [0.87-1.58],0.3051732719583504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,16036,144,0.88 [0.58-1.32],0.5305959749079722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,18107,161,1.01 [0.84-1.20],0.9389344719620224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,18697,171,0.96 [0.87-1.07],0.4805576299506751
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,18524,168,1.09 [0.87-1.37],0.4294824220863121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,15604,137,0.89 [0.66-1.20],0.4323179745706961
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,18697,171,0.82 [0.64-1.05],0.1078972076598616
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",16064,141,0.98 [0.76-1.27],0.9006519271350167
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,18197,158,0.71 [0.54-0.94],0.0178765065204648
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,18530,168,1.14 [0.71-1.83],0.5981203590382638
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,16032,144,1.57 [1.15-2.14],0.0045709594927529
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,15666,142,1.62 [1.00-2.60],0.0477342864354995
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,15673,134,0.91 [0.69-1.21],0.528519246562646
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,16036,144,1.86 [1.42-2.45],8.488519950578523e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,15738,143,0.86 [0.64-1.15],0.3114165567215714
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,15598,136,0.95 [0.70-1.28],0.7168635974519395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,16058,142,0.89 [0.57-1.37],0.5849765254923551
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,16089,144,0.87 [0.69-1.09],0.2212295387026586
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,15807,138,0.93 [0.79-1.08],0.336264474900107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,18440,167,0.97 [0.86-1.09],0.6253586851919649
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,16427,153,1.19 [0.72-1.97],0.4975378293079956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,16032,144,0.71 [0.47-1.07],0.0991002232025568
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,18440,167,1.25 [0.86-1.82],0.244494942252203
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,15529,136,0.81 [0.61-1.07],0.1403855903254236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,16049,143,1.04 [0.72-1.50],0.8274899985007559
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,18216,160,0.97 [0.79-1.19],0.7748846752499767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,15807,138,0.74 [0.52-1.06],0.1046605258687986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,18133,164,0.93 [0.78-1.11],0.4103662131701706
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",15673,134,0.88 [0.68-1.13],0.3017125724376467
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",16032,144,0.91 [0.59-1.39],0.6521438347936541
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,16058,142,1.08 [0.84-1.40],0.554098800219275
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,18133,164,0.82 [0.59-1.14],0.2421428055977312
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,18440,167,0.94 [0.80-1.09],0.3982902980972478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,18524,168,1.01 [0.85-1.20],0.906152149001575
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,15738,143,0.92 [0.75-1.11],0.3780225338787939
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,18379,166,0.98 [0.85-1.12],0.7721205307538986
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,18379,166,0.95 [0.80-1.12],0.5337964398678875
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,18107,161,1.04 [0.88-1.22],0.6630057885498724
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,15673,134,1.10 [0.80-1.52],0.5612856521590607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,18356,166,1.03 [0.90-1.18],0.6223856743436265
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,18197,158,1.04 [0.88-1.23],0.6666612876276192
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,15794,144,1.44 [1.01-2.05],0.0411913630553264
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,18729,168,0.93 [0.59-1.46],0.7428494335375465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,16089,144,2.40 [1.84-3.14],1.4106412071074954e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,15807,138,0.82 [0.57-1.16],0.262339898254214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,16089,144,1.17 [0.69-1.97],0.5555261559664395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,18133,164,1.03 [0.94-1.13],0.5003003372791482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",15673,134,0.87 [0.54-1.38],0.5490930898031043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,16032,144,1.22 [1.02-1.46],0.028113269389222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,18133,164,1.06 [0.91-1.25],0.4473898335062976
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,15563,139,0.97 [0.66-1.43],0.8914069210224214
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,18574,169,0.85 [0.46-1.57],0.6053702851247567
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,15604,137,1.37 [0.81-2.33],0.2442189866194465
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,15778,138,0.77 [0.62-0.97],0.0250144878791912
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,15673,134,0.91 [0.69-1.19],0.4830144563153085
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,15807,138,0.75 [0.45-1.25],0.2768060745080564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,16113,144,0.54 [0.26-1.12],0.0978434521446893
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,15598,136,0.84 [0.63-1.14],0.2721609805240303
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,18452,166,0.95 [0.79-1.13],0.5641604247601606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,18567,166,1.08 [0.85-1.37],0.5220722073035096
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,18533,164,1.49 [1.09-2.03],0.0121336580681224
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,18501,163,0.90 [0.57-1.41],0.6336675290727966
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,18520,169,1.33 [1.02-1.72],0.0332806526457207
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,18617,165,1.31 [0.92-1.87],0.1327850277250518
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,16032,144,1.09 [0.94-1.26],0.2445568345308409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,18524,168,1.31 [0.99-1.74],0.0632564361577309
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,18718,169,1.07 [0.76-1.51],0.7024354360607387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,16032,144,0.88 [0.64-1.19],0.3993432562979403
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,18444,163,0.97 [0.58-1.63],0.913808077421288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,15604,137,1.66 [0.97-2.85],0.0669428714731432
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,18574,169,1.35 [0.91-2.00],0.1330658508062417
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,18759,168,1.14 [0.72-1.80],0.5669620005875076
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,18495,165,0.83 [0.69-1.00],0.0448546215977078
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,16110,145,1.17 [0.64-2.14],0.6037317729751387
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,15502,136,0.87 [0.69-1.09],0.217421151360606
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,18528,166,1.66 [1.09-2.54],0.0189039912239082
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,18530,168,1.24 [0.88-1.76],0.2173854242009218
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,18561,164,0.90 [0.67-1.23],0.5167274208305935
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,18444,165,1.55 [1.03-2.34],0.0353510761172599
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,18197,158,0.80 [0.55-1.15],0.2270621157836274
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,15563,139,1.05 [0.91-1.21],0.5199865725500927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,15486,137,1.33 [0.85-2.08],0.2143535100462121
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,15993,144,0.89 [0.74-1.07],0.2087282460716985
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,18697,171,1.65 [1.04-2.62],0.0331539063407077
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,17993,157,0.94 [0.83-1.06],0.3060700626190341
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,18759,168,1.31 [0.91-1.89],0.1515640111317062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",18105,164,1.31 [1.00-1.72],0.0531610453614791
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,15807,138,1.77 [1.50-2.10],3.8776553732968335e-11
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,18617,166,1.53 [1.12-2.09],0.0079483247189549
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,16089,144,0.84 [0.56-1.27],0.4129153325097675
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,16058,142,0.95 [0.78-1.14],0.5600576919385879
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,18356,161,1.44 [0.89-2.32],0.138146903333005
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,16089,144,1.32 [0.89-1.96],0.1643786975686635
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,18589,167,0.99 [0.89-1.10],0.84427858743116
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,18530,168,1.07 [0.76-1.51],0.6860196532565643
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,18478,165,2.46 [1.33-4.54],0.0040611702979197
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,18574,169,0.95 [0.80-1.12],0.514505510652761
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,15598,136,0.63 [0.40-1.00],0.0502509198893114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",15807,138,1.43 [1.09-1.89],0.0109075987544812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,15604,137,2.25 [1.33-3.82],0.0025010779734607
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,15807,138,1.25 [0.62-2.53],0.526294341612114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,18751,169,1.08 [0.86-1.35],0.5011065092998983
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,15604,137,0.98 [0.55-1.76],0.95024731722722
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,15673,134,0.97 [0.71-1.32],0.8409707254527389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,15807,138,1.00 [0.74-1.34],0.9980035432109592
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,15563,139,0.90 [0.60-1.35],0.615604129045685
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,15563,139,0.92 [0.67-1.26],0.6162717483244612
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,16036,144,0.93 [0.80-1.08],0.3424606927191011
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,16032,144,0.88 [0.70-1.10],0.261659089180287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,15641,140,0.95 [0.73-1.23],0.6886058191811015
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,16064,141,1.04 [0.74-1.45],0.8425872945932233
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,15529,136,1.03 [0.68-1.57],0.8716533606145703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,15598,136,1.02 [0.82-1.26],0.8880751327485107
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,16026,142,0.80 [0.52-1.23],0.3142522780077622
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,18440,167,0.89 [0.76-1.04],0.1421188011673872
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,18290,165,1.27 [0.88-1.84],0.1984515692026373
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,18530,168,1.08 [0.90-1.29],0.4050384259734396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,18617,166,1.87 [1.43-2.45],5.042764077027037e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,18172,158,1.87 [1.54-2.28],3.1431386107152977e-10
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,16036,144,1.25 [0.93-1.68],0.1383864868466515
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,18216,160,1.00 [0.68-1.46],0.9953304732611832
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,15738,143,0.83 [0.64-1.09],0.1750562784622955
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,18379,166,2.14 [1.58-2.89],8.816642039974922e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,18379,166,1.40 [1.20-1.64],1.5306929250413463e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,18570,165,0.95 [0.72-1.26],0.7425628483388824
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,18751,169,1.56 [1.12-2.17],0.0081797480830389
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,18498,166,1.02 [0.64-1.64],0.9243026192824704
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,18574,169,0.99 [0.67-1.45],0.9565283566054904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,18528,166,3.69 [3.13-4.34],8.722936165646858e-56
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,18216,160,3.41 [2.84-4.08],3.3793116888313806e-40
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,18528,166,1.83 [1.21-2.77],0.0040760361694628
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,15738,143,2.48 [1.72-3.58],1.146415312244282e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,18701,165,1.74 [1.19-2.56],0.0046511767379532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,18530,168,1.96 [1.31-2.93],0.0010376170372653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,18530,168,1.72 [1.42-2.10],5.3546756640579054e-08
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,18697,171,1.38 [0.85-2.23],0.1925089538357914
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,18718,169,4.54 [3.53-5.86],1.4297661544536362e-31
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,18379,166,1.66 [1.37-2.01],2.732677978004109e-07
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,18697,171,3.06 [2.50-3.75],1.4812738800377662e-27
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,18379,166,10.75 [0.00-210287.90],0.6375159107376829
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,18751,169,1.40 [0.82-2.38],0.2200848337123766
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,18524,168,1.27 [1.01-1.59],0.0370143433853288
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,18751,169,1.01 [0.63-1.64],0.9544296774078702
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,18589,167,0.95 [0.57-1.60],0.8570233804915084
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,18728,168,0.71 [0.42-1.19],0.1933823084621621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,18379,166,0.95 [0.75-1.21],0.6862933117437342
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,16098,144,2.99 [2.20-4.06],2.873977634955671e-12
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,16058,142,0.96 [0.80-1.16],0.6844742594493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,16098,144,0.92 [0.64-1.34],0.6768979650187513
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",18197,158,1.00 [0.84-1.18],0.9551297891179767
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,15807,138,1.18 [0.75-1.85],0.4842991728832452
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,18379,166,0.74 [0.53-1.03],0.078764243271165
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,18530,168,0.65 [0.38-1.10],0.1092209513311193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,16089,144,0.93 [0.75-1.15],0.4975836817188246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,16036,144,1.03 [0.90-1.18],0.6533910268004998
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",15529,136,0.62 [0.41-0.94],0.0251540066569852
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,15604,137,0.96 [0.78-1.19],0.7199068908700633
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,15641,140,1.15 [0.87-1.52],0.3209580637453504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,18107,161,1.18 [0.86-1.61],0.2979770562226715
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,15604,137,1.23 [1.03-1.47],0.0238938059450562
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,15395,140,0.94 [0.69-1.29],0.7165722032647677
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,18197,158,1.07 [0.67-1.69],0.7867676562218284
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,15673,134,1.31 [0.80-2.13],0.2844469635202193
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,15673,134,1.18 [0.82-1.69],0.3772502712104603
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,15738,143,0.89 [0.77-1.03],0.114291127898908
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,16089,144,1.76 [1.01-3.09],0.0479858572021129
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,15563,139,1.13 [0.80-1.58],0.4913046354928639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,18107,161,1.06 [0.87-1.28],0.5687370461345493
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,18380,164,1.04 [0.77-1.40],0.8120612418892579
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,15807,138,1.09 [0.90-1.32],0.4022464859379784
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,18133,164,0.88 [0.60-1.29],0.5165630633190573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,15563,139,1.39 [1.12-1.72],0.0026119863123851
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,15529,136,0.85 [0.64-1.14],0.2704050270871241
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,18725,169,1.04 [0.80-1.35],0.782783640255392
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,16064,141,1.13 [0.77-1.68],0.5272121050554621
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,15604,137,0.96 [0.52-1.78],0.89977046380573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,18216,160,1.03 [0.84-1.26],0.7762973893344035
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,18524,168,0.95 [0.78-1.16],0.5936943892520257
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",15604,137,1.45 [1.04-2.02],0.0285357875876736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,15563,139,0.76 [0.50-1.15],0.1905371734312652
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,15807,138,0.90 [0.74-1.11],0.331010284554841
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,16098,144,0.81 [0.66-1.00],0.0496335240317395
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,18498,166,1.21 [0.94-1.56],0.1358703880094208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,16110,145,0.86 [0.63-1.17],0.338325120801108
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,18530,168,2.06 [1.40-3.02],0.0002299738039371
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,18701,165,0.92 [0.74-1.15],0.4630822613943666
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,18524,168,0.84 [0.70-1.01],0.0694293805873775
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,15780,138,0.93 [0.72-1.21],0.6067616066899528
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,16036,144,0.98 [0.85-1.14],0.8129828272254391
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,15529,136,0.80 [0.57-1.12],0.1935382779441934
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,15673,134,0.81 [0.64-1.03],0.0879650143435239
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,18524,168,0.93 [0.80-1.09],0.3890195302623287
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,16032,144,1.02 [0.85-1.23],0.8375214018816409
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,15563,139,0.88 [0.62-1.26],0.4964522797562762
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,15604,137,0.92 [0.72-1.17],0.4976548151842583
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,16064,141,0.95 [0.74-1.22],0.6853322902158268
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,18528,166,1.03 [0.85-1.25],0.7679993955662421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,18197,158,1.19 [0.98-1.45],0.0862034527100497
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,15563,139,0.84 [0.55-1.29],0.4343026407160117
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,18197,158,0.97 [0.82-1.16],0.7499184688863625
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,15563,139,0.90 [0.63-1.28],0.5510330979701399
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,15598,136,0.84 [0.69-1.03],0.1012487373662572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,16036,144,1.00 [0.84-1.19],0.9900787755554384
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,15604,137,0.83 [0.54-1.27],0.389246486992623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,18104,164,0.93 [0.77-1.12],0.4611157703664698
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,15673,134,0.88 [0.62-1.24],0.4605490950691545
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTN,Titin,15563,139,0.99 [0.77-1.25],0.9058493660322144
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,15947,141,0.64 [0.34-1.23],0.1813853409945867
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,15598,136,0.74 [0.41-1.34],0.3182272253483656
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,16098,144,0.90 [0.74-1.08],0.2627325159607532
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,15807,138,0.93 [0.73-1.17],0.5322142202229128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,18379,166,1.02 [0.87-1.20],0.7708190416612212
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,15852,142,1.15 [0.80-1.64],0.4492232465092997
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,18574,169,1.06 [0.64-1.73],0.8310256972027128
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,18697,171,1.03 [0.85-1.25],0.7689332574191878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,16058,142,0.79 [0.57-1.09],0.150551193001101
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,15571,136,1.05 [0.90-1.22],0.5552365688070504
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",18530,168,0.98 [0.73-1.32],0.8838368453550778
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,18412,163,0.94 [0.76-1.16],0.5617653011035904
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,18528,166,1.47 [0.91-2.39],0.1175789806878229
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",15604,137,1.26 [0.96-1.65],0.0912378561113269
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,18440,167,0.85 [0.56-1.28],0.4287767628287251
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,16032,144,0.94 [0.54-1.64],0.8246762995737498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,16089,144,1.12 [0.86-1.45],0.3911480119997236
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,15604,137,0.89 [0.66-1.21],0.4677261232170902
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,15563,139,0.79 [0.55-1.11],0.1749623989843823
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,15738,143,0.87 [0.68-1.11],0.2652682546403631
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,16036,144,0.92 [0.82-1.03],0.1383749055888757
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,15563,139,1.07 [0.92-1.24],0.3943174561770749
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,15563,139,1.14 [0.73-1.76],0.5669103637530208
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,18379,166,1.84 [1.33-2.55],0.000238677365682
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,18694,167,0.93 [0.72-1.20],0.5686156959113573
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,15604,137,0.70 [0.37-1.35],0.2915766122217222
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,15529,136,0.86 [0.63-1.18],0.3486414372396563
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,16032,144,0.83 [0.52-1.33],0.4406448664823672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,16089,144,0.87 [0.72-1.05],0.1358477480281699
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,15598,136,1.01 [0.72-1.41],0.9439530199930366
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,15769,138,0.99 [0.72-1.36],0.9529054256816472
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,15738,143,0.83 [0.66-1.06],0.1445941792364869
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,15673,134,0.93 [0.72-1.21],0.5896000136850543
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,18440,167,1.00 [0.86-1.17],0.9603970444887678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,16032,144,0.97 [0.77-1.21],0.7831770129194572
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,16058,142,1.38 [0.96-1.99],0.0794850835558623
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,15563,139,0.92 [0.75-1.12],0.4116399158429316
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,18197,158,0.93 [0.79-1.08],0.3383144207965478
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,18107,161,1.02 [0.78-1.34],0.8884564295156396
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,18197,158,1.26 [1.01-1.57],0.0440584758169615
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,15604,137,0.88 [0.73-1.07],0.2051685849702125
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,18524,168,0.93 [0.78-1.10],0.3815868648629964
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,18256,162,0.75 [0.45-1.26],0.2842462464193043
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,16110,145,0.88 [0.71-1.10],0.2721553115777774
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,18440,167,1.40 [0.69-2.81],0.3477993447773737
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,15598,136,0.90 [0.76-1.07],0.2435852624497968
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,18594,165,5.64 [3.73-8.53],2.8126721861430665e-16
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,18697,171,1.39 [0.89-2.17],0.1458274850334597
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,15529,136,0.81 [0.63-1.03],0.0882832437246639
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,18695,168,1.12 [0.89-1.42],0.3291468868262055
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,15604,137,0.86 [0.49-1.52],0.6092315150859253
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,18574,169,0.89 [0.70-1.13],0.3293777163022552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,18724,169,1.15 [0.80-1.64],0.4580012865609145
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,16064,141,0.75 [0.44-1.28],0.2900303432357261
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,18197,158,1.00 [0.89-1.13],0.9622256883753556
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,15641,140,0.90 [0.45-1.81],0.7680277341759552
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,16089,144,1.19 [0.78-1.82],0.4079568863861771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,18440,167,1.12 [0.91-1.38],0.2989280293145629
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,16110,145,0.76 [0.62-0.93],0.0080681925048127
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,18440,167,1.31 [0.96-1.78],0.0837634809115723
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,15807,138,1.00 [0.78-1.28],0.969916848437276
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,18440,167,1.03 [0.87-1.23],0.6958125870212664
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,16032,144,0.91 [0.76-1.08],0.2650070160081771
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,18440,167,0.95 [0.79-1.13],0.5618527795933109
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,16032,144,1.31 [0.88-1.96],0.1810184685298837
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,15563,139,0.95 [0.58-1.56],0.843378464681114
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,16032,144,1.35 [1.08-1.69],0.0072972954327369
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,18508,168,1.70 [1.24-2.33],0.0008859539092247
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,18499,166,0.92 [0.73-1.15],0.4605121514184421
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,16058,142,0.82 [0.53-1.27],0.3736159030533381
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,18133,164,1.00 [0.76-1.31],0.9958876526799924
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,15807,138,0.71 [0.44-1.15],0.163340352474424
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,18197,158,0.75 [0.57-0.98],0.0374654092459854
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,18697,171,0.93 [0.76-1.12],0.4387323035268365
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,18107,161,1.33 [0.85-2.07],0.2112562113783206
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,15738,143,0.95 [0.71-1.26],0.7079691034877482
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,18678,165,1.00 [0.72-1.39],0.9793118429562132
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,15529,136,1.03 [0.84-1.27],0.7654816529914918
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,18316,165,0.92 [0.65-1.30],0.64220923501878
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,16064,141,0.78 [0.51-1.18],0.2414800037939315
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,18759,168,0.97 [0.81-1.16],0.7338740278893445
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",18530,168,1.67 [1.17-2.39],0.0046133389487871
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,18216,160,1.02 [0.82-1.27],0.8570967931177826
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,18197,158,0.96 [0.82-1.11],0.5559335530385668
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,18133,164,0.87 [0.75-1.02],0.0963035323038812
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,16058,142,1.01 [0.82-1.25],0.9015035103660703
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,15604,137,0.98 [0.74-1.29],0.8682103653344172
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,16032,144,1.49 [1.06-2.10],0.0224405844260564
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,15695,142,0.94 [0.68-1.28],0.6831727818778375
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,18666,165,1.11 [0.89-1.38],0.342963459735442
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,17594,160,1.65 [1.20-2.25],0.0017929664482441
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",18309,163,0.73 [0.52-1.03],0.0716225777176282
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",18528,166,0.84 [0.56-1.27],0.4108147814662355
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,18701,165,1.06 [0.71-1.60],0.7642671368620576
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,18216,160,1.05 [0.64-1.70],0.8549399891481404
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,18379,166,1.10 [0.85-1.43],0.4566576715200041
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,18701,165,1.42 [1.15-1.74],0.0010080856535948
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,18671,168,1.11 [0.73-1.66],0.6305413429136062
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,15604,137,0.92 [0.69-1.23],0.5708370048580099
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,18574,169,1.04 [0.92-1.18],0.4971044122992014
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,18133,164,0.88 [0.60-1.29],0.5150157642904007
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,16058,142,1.79 [1.07-2.98],0.0257916241100589
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",16036,144,0.95 [0.85-1.06],0.3502246444753459
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,18440,167,0.96 [0.86-1.09],0.5539546541518736
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,16032,144,1.12 [0.69-1.82],0.6444565426910747
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,15563,139,0.89 [0.68-1.16],0.3989567694335927
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,18216,160,0.90 [0.76-1.06],0.219720341706899
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,15738,143,0.86 [0.69-1.08],0.1861088791014358
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,15604,137,1.56 [0.91-2.69],0.1077274553101653
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,15604,137,1.77 [1.35-2.32],4.175554019931506e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,18107,161,0.97 [0.80-1.18],0.7639843222908956
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,18197,158,1.66 [1.34-2.05],3.245351276517112e-06
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,15563,139,1.25 [1.01-1.56],0.0401687715944672
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,16036,144,0.85 [0.71-1.02],0.07694200480617
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,16058,142,1.74 [1.35-2.23],1.4912948207756862e-05
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,15604,137,1.02 [0.66-1.59],0.9207630708207972
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,15807,138,0.95 [0.72-1.26],0.7228033233517277
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,16032,144,0.95 [0.77-1.18],0.6399773866505246
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,16036,144,1.24 [1.00-1.54],0.0548426897479835
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,16032,144,0.74 [0.54-1.02],0.069328837658498
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,15641,140,0.98 [0.92-1.04],0.5712657157319678
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,15529,136,0.43 [0.21-0.87],0.0185447564870094
Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,15598,136,0.92 [0.76-1.12],0.4001865781740245
